[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1980
1. Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, Ben-Porat LS, Minsky BD, Cohen AM, Paty PB: T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg; 2005 Oct;242(4):472-7; discussion 477-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
  • BACKGROUND: Recent studies suggest local excision may be acceptable treatment of T1 adenocarcinoma of the rectum, but there is little comparative data with radical surgery to assess outcomes and quantify risk.
  • We performed a retrospective evaluation of patients with T1 rectal cancers treated by either transanal excision or radical resection at our institution to assess patient selection, cancer recurrence, and survival.
  • METHODS: All patients who underwent surgery for T1 adenocarcinomas of the rectum (0-15 cm from anal verge) by either transanal excision (TAE) or radical resection (RAD) between January 1987 and January 2004 were identified from a prospective database.
  • RAD surgery was associated with higher tumor location in the rectum, slightly larger tumor size, a similar rate of adverse histology, and a lymph node metastasis rate of 18%.
  • CONCLUSION: Despite a similar risk profile in the 2 surgical groups, patients with T1 rectal cancer treated by local excision were observed to have a 3- to 5-fold higher risk of tumor recurrence compared with patients treated by radical surgery.
  • Radical resection is the more definitive surgical treatment of T1 rectal cancers.
  • [MeSH-major] Adenocarcinoma / surgery. Decision Making. Proctocolectomy, Restorative / methods. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy. Colonoscopy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Risk Assessment. Risk Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2000 Mar 1;92(5):388-96 [10699069.001]
  • [Cites] Ann Surg. 2000 Mar;231(3):345-51 [10714627.001]
  • [Cites] Arch Pathol Lab Med. 2000 Jul;124(7):979-94 [10888773.001]
  • [Cites] Dis Colon Rectum. 2000 Aug;43(8):1064-71; discussion 1071-4 [10950004.001]
  • [Cites] Dis Colon Rectum. 2000 Oct;43(10 Suppl):S59-68 [11052480.001]
  • [Cites] Semin Surg Oncol. 2000 Dec;19(4):367-75 [11241919.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] J Clin Oncol. 2002 Apr 1;20(7):1744-50 [11919230.001]
  • [Cites] Dis Colon Rectum. 2002 Jul;45(7):875-9 [12130873.001]
  • [Cites] Am Surg. 2003 Aug;69(8):675-8; discussion 678 [12953825.001]
  • [Cites] Gut. 1977 Dec;18(12):1045-50 [606631.001]
  • [Cites] Lancet. 1989 Aug 12;2(8659):353-6 [2569552.001]
  • [Cites] Cancer. 1992 Jan 15;69(2):322-6 [1728363.001]
  • [Cites] World J Surg. 1992 May-Jun;16(3):478-85 [1589984.001]
  • [Cites] Am Surg. 1993 Jul;59(7):400-4 [8323072.001]
  • [Cites] Dis Colon Rectum. 1995 Apr;38(4):411-8 [7720451.001]
  • [Cites] J Am Coll Surg. 1996 Jun;182(6):495-502 [8646349.001]
  • [Cites] Dis Colon Rectum. 1996 Jul;39(7):780-7 [8674371.001]
  • [Cites] Dis Colon Rectum. 1997 Apr;40(4):388-92 [9106685.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):777-83 [9240646.001]
  • [Cites] World J Surg. 1997 Sep;21(7):706-14 [9276701.001]
  • [Cites] World J Surg. 1997 Sep;21(7):715-20 [9276702.001]
  • [Cites] Int J Cancer. 1997 Dec 19;74(6):664-9 [9421366.001]
  • [Cites] Semin Surg Oncol. 1998 Sep;15(2):101-13 [9730416.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):841-6 [10386641.001]
  • [Cites] Dis Colon Rectum. 1999 Jul;42(7):881-5 [10411434.001]
  • [Cites] Arch Surg. 1999 Aug;134(8):863-7; discussion 867-8 [10443810.001]
  • [Cites] Ann Surg Oncol. 1999 Jul-Aug;6(5):433-41 [10458680.001]
  • [Cites] Ann Surg. 1999 Oct;230(4):544-52; discussion 552-4 [10522724.001]
  • [Cites] J Gastrointest Surg. 2004 Dec;8(8):1032-9; discussion 1039-40 [15585391.001]
  • [Cites] Dis Colon Rectum. 2004 Nov;47(11):1773-9 [15622568.001]
  • [Cites] Dis Colon Rectum. 2005 Mar;48(3):483-92 [15747079.001]
  • [Cites] Dis Colon Rectum. 2005 Jun;48(6):1169-75 [15793645.001]
  • [Cites] Ann Surg. 2002 Oct;236(4):522-29; discussion 529-30 [12368681.001]
  • [CommentIn] Ann Surg. 2007 Feb;245(2):338-9 [17245194.001]
  • (PMID = 16192807.001).
  • [ISSN] 0003-4932
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1402341
  •  go-up   go-down


2. Schäfer H, Hölscher AH: T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg; 2007 Feb;245(2):338-9
MedlinePlus Health Information. consumer health - Colonoscopy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
  • [MeSH-major] Adenocarcinoma / pathology. Colectomy / methods. Colonoscopy / methods. Rectal Neoplasms / pathology
  • [MeSH-minor] Decision Making. Humans. Neoplasm Staging. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1995 Feb;38(2):177-81 [7851173.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] Dis Colon Rectum. 2002 Jul;45(7):875-9 [12130873.001]
  • [Cites] Surg Endosc. 2003 Aug;17(8):1283-7 [12739119.001]
  • [Cites] Ann Surg. 2005 Oct;242(4):472-7; discussion 477-9 [16192807.001]
  • [Cites] Dis Colon Rectum. 1996 Aug;39(8):886-92 [8756844.001]
  • [Cites] Dis Colon Rectum. 1996 Sep;39(9):969-76 [8797643.001]
  • [Cites] Surg Endosc. 1998 Sep;12(9):1145-8 [9716769.001]
  • [Cites] Chirurg. 2005 Apr;76(4):379-84 [15502890.001]
  • [CommentOn] Ann Surg. 2005 Oct;242(4):472-7; discussion 477-9 [16192807.001]
  • (PMID = 17245194.001).
  • [ISSN] 0003-4932
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1876983
  •  go-up   go-down


3. Paran H, Edelstein E, Klein B, Gutman M: Extensive colonic ischemia following treatment with bevacizumab, fluouracil and CPT-11 in a young patient with advanced adenocarcinoma of the rectum. Isr Med Assoc J; 2007 Jun;9(6):488-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extensive colonic ischemia following treatment with bevacizumab, fluouracil and CPT-11 in a young patient with advanced adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antibodies, Monoclonal / adverse effects. Antineoplastic Combined Chemotherapy Protocols. Colitis, Ischemic / chemically induced. Rectal Neoplasms / drug therapy

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17642404.001).
  • [ISSN] 1565-1088
  • [Journal-full-title] The Israel Medical Association journal : IMAJ
  • [ISO-abbreviation] Isr. Med. Assoc. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Israel
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 2S9ZZM9Q9V / Bevacizumab; 7673326042 / irinotecan; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin; IFL protocol
  •  go-up   go-down


Advertisement
4. Mallik AA, Katchy KC: Clear cell adenocarcinoma of the rectum. Med Princ Pract; 2005 Jan-Feb;14(1):58-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell adenocarcinoma of the rectum.
  • OBJECTIVE: To document the first case of clear cell adenocarcinoma of the rectum (a rare entity) in Kuwait.
  • CLINICAL PRESENTATION AND INTERVENTION: A 36-year-old female presented with a 1-year history of constipation and bleeding per rectum.
  • After multiple biopsies an abdomino-perineal resection was performed for the rectal mass.
  • CONCLUSION: This report illustrates a case of intestinal clear cell adenocarcinoma with lymph node metastasis that suggested a poor prognosis.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15608484.001).
  • [ISSN] 1011-7571
  • [Journal-full-title] Medical principles and practice : international journal of the Kuwait University, Health Science Centre
  • [ISO-abbreviation] Med Princ Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


5. Piana S, Asioli S, Foroni M: Oncocytic adenocarcinoma of the rectum arising on a villous adenoma with oncocytic features. Virchows Arch; 2006 Feb;448(2):228-31
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncocytic adenocarcinoma of the rectum arising on a villous adenoma with oncocytic features.
  • Rectal adenocarcinoma with diffuse oncocytic features is a very rare lesion, having been reported only once in the English literature.
  • We describe a case of oncocytic adenocarcinoma of the rectum, associated with a villous adenoma, arising on a 66-year-old man.
  • On histological examination, the adenocarcinoma was composed of neoplastic glands lined by a strongly eosinophilic, granular epithelium that deeply infiltrated the rectal wall.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma, Villous / pathology. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16450120.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / CDX2 protein, human; 0 / Carcinoembryonic Antigen; 0 / Homeodomain Proteins; 0 / Keratin-20; 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


6. Jurach MT, Meurer L, Moreira LF: Expression of the p53 protein and clinical and pathologic correlation in adenocarcinoma of the rectum. Arq Gastroenterol; 2006 Jan-Mar;43(1):14-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of the p53 protein and clinical and pathologic correlation in adenocarcinoma of the rectum.
  • BACKGROUND: p53 is a tumor suppressor gene that has been implicated in the pathogenesis of a wide range of tumors, including colorectal cancer.
  • PATIENTS AND METHODS: Immunohistochemical staining for p53 protein was performed in a series of 83 patients with rectal cancer with a follow-up of at least 5 years.
  • [MeSH-major] Adenocarcinoma / metabolism. Rectal Neoplasms / metabolism. Tumor Suppressor Protein p53 / metabolism
  • [MeSH-minor] Female. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Recurrence, Local. Neoplasm Staging. Prognosis. Retrospective Studies. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16699612.001).
  • [ISSN] 0004-2803
  • [Journal-full-title] Arquivos de gastroenterologia
  • [ISO-abbreviation] Arq Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


7. Gaud U, Goyal T, Shukla M, Kumar V, Pandey M: Synchronous occurrence of adenocarcinoma of the rectum with squamous cell carcinoma of a retrorectal cyst: report of a case and review of the literature. BMJ Case Rep; 2009;2009

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous occurrence of adenocarcinoma of the rectum with squamous cell carcinoma of a retrorectal cyst: report of a case and review of the literature.
  • Rarely, malignant transformation can occur in these cysts.
  • We report here the case of a middle-aged man who had synchronous presentation of adenocarcinoma of the rectum and squamous cell carcinoma in a retrorectal cyst.
  • The patient presented with rectal bleeding and constipation, and underwent abdominoperineal resection and complete excision of the cyst.
  • Postoperative histopathological examination showed adenocarcinoma of the rectum and squamous cell carcinoma of the cyst.
  • Synchronous occurrence of rectal cancer with carcinoma in a retrorectal cyst has not been previously reported in the literature in English.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann R Coll Surg Engl. 2000 Mar;82(2):146 [10743441.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jun;170(6):1488-90 [9609159.001]
  • [Cites] Radiographics. 2001 May-Jun;21(3):575-84 [11353107.001]
  • [Cites] Clin Radiol. 1992 Apr;45(4):288-9 [1395393.001]
  • [Cites] Am Surg. 2004 Nov;70(11):1007-9 [15586516.001]
  • [Cites] Histol Histopathol. 2005 Oct;20(4):1065-9 [16136488.001]
  • [Cites] Ann R Coll Surg Engl. 2005 Sep;87(5):W8-10 [16176703.001]
  • [Cites] World J Gastroenterol. 2005 Oct 21;11(39):6225-7 [16273657.001]
  • [Cites] Br J Surg. 1986 May;73(5):377 [3708289.001]
  • [Cites] Crit Rev Diagn Imaging. 1984;21(4):307-74 [6428808.001]
  • [Cites] Can J Surg. 1981 Jul;24(4):351-2 [7272850.001]
  • [Cites] J Clin Pathol. 1999 Apr;52(4):310-2 [10474528.001]
  • [Cites] Ann R Coll Surg Engl. 1999 May;81(3):205-6 [10364957.001]
  • [Cites] Am Surg. 1995 Nov;61(11):997-1000 [7486435.001]
  • [Cites] Br J Radiol. 1999 Sep;72(861):896-8 [10645197.001]
  • [Cites] Am J Gastroenterol. 2000 May;95(5):1344-7 [10811351.001]
  • [Cites] Dis Colon Rectum. 2001 Mar;44(3):447 [11289294.001]
  • [Cites] J Pediatr Surg. 1990 Sep;25(9):980-4 [2213451.001]
  • [Cites] J R Soc Med. 1979 Dec;72(12):935-7 [233246.001]
  • [Cites] Arch Pathol Lab Med. 2000 May;124(5):725-9 [10782156.001]
  • (PMID = 21686338.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3027582
  •  go-up   go-down


8. Hisham RB, Thuaibah H, Gul YA: Mucinous adenocarcinoma of the rectum with breast and ocular metastases. Asian J Surg; 2006 Apr;29(2):95-7
MedlinePlus Health Information. consumer health - Eye Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous adenocarcinoma of the rectum with breast and ocular metastases.
  • We present the case of a 32-year-old woman who, 10 months after abdominoperineal resection and total mesorectal excision for a locally advanced mucinous adenocarcinoma of the rectum, presented with local recurrence and metastases to the breast, spine, the left eye and orbit.
  • The patient died 2 months later, with disseminated cancer.
  • To the best of our knowledge, breast as well as ocular metastasis in a patient with mucinous adenocarcinoma of the rectum has never been reported and, therefore, needs to be documented.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16644510.001).
  • [ISSN] 1015-9584
  • [Journal-full-title] Asian journal of surgery
  • [ISO-abbreviation] Asian J Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


9. Adibelli ZH, Yildirim M, Ozan E, Oztekin O, Kucukzeybek B: Fibroadenoma of the breast in a man associated with adenocarcinoma of the rectum and polyposis coli. JBR-BTR; 2010 Jan-Feb;93(1):12-4
MedlinePlus Health Information. consumer health - Male Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibroadenoma of the breast in a man associated with adenocarcinoma of the rectum and polyposis coli.
  • We present herein the first case of a fibroadenoma of the breast in a 68-year-old man with adenocarcinoma of the rectum and polyposis coli.
  • [MeSH-major] Adenocarcinoma / complications. Adenomatous Polyposis Coli / complications. Breast Neoplasms, Male / complications. Fibroadenoma / complications. Rectal Neoplasms / complications
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Mammography. Ultrasonography, Mammary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20397428.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


10. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD: Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol; 2006 Sep 1;24(25):4078-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
  • PURPOSE: Treatment of rectal cancer with neoadjuvant radiotherapy has been shown to reduce local recurrence and improve overall survival.
  • The role of chemoradiotherapy in patients with T2, N0 and early T3, N0 rectal cancer, treated by radical surgery with total mesorectal excision, remains controversial.
  • PATIENTS AND METHODS: One hundred patients with primary T2-3, N0 adenocarcinoma of the rectum, uniformly treated by surgery alone, were studied.
  • CONCLUSION Patients with T2-3, N0 rectal cancers and either lymphovascular invasion or elevated CEA levels have reduced survival and a higher incidence of PR, and should be considered for future randomized trials.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Neoplasm Recurrence, Local / diagnosis. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoembryonic Antigen / blood. Female. Follow-Up Studies. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prospective Studies. Risk Assessment. Risk Factors. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16943525.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  •  go-up   go-down


11. Gasljevic G, Lamovec J: Primary clear cell adenocarcinoma of the rectum: a case report. Int J Colorectal Dis; 2010 Oct;25(10):1259-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary clear cell adenocarcinoma of the rectum: a case report.
  • [MeSH-major] Adenocarcinoma, Clear Cell / surgery. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20405292.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Germany
  •  go-up   go-down


12. Dias AR, Pinto RA, Mory E, Silva IC, Siqueira SA, Nahas SC, Cecconello I, Wexner SD: Synchronous collision malignant melanoma and adenocarcinoma of the rectum. Tech Coloproctol; 2010 Jun;14(2):181-4
MedlinePlus Health Information. consumer health - Melanoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous collision malignant melanoma and adenocarcinoma of the rectum.
  • Colorectal collisions are particularly unusual; here, we report the exceedingly rare case of a 61-year-old man with malignant melanoma and adenocarcinoma colliding in the rectum.
  • This article discusses the concepts about cancer development, which are overlooked by this hypothesis, another theory to explain that this rare occurrence involves microenvironment changes.
  • [MeSH-major] Adenocarcinoma / pathology. Melanoma / pathology. Neoplasms, Multiple Primary / pathology. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20309715.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


13. Wentworth S, Russell GB, Tuner II, Levine EA, Mishra G, Waters GS, Blackstock AW: Long-term results of local excision with and without chemoradiation for adenocarcinoma of the rectum. Clin Colorectal Cancer; 2005 Jan;4(5):332-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term results of local excision with and without chemoradiation for adenocarcinoma of the rectum.
  • The role of local excision for rectal carcinoma remains controversial.
  • We reviewed 285 patients undergoing curative resection for rectal cancer between 1984 and 2001.
  • The rate of local failure (16%) is comparable to that observed in the Cancer and Leukemia Group B (CALGB) 8984 prospective study and suggests that highly selected patients undergoing local excision can expect good local control of rectal cancer.
  • [MeSH-major] Rectal Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma. Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Chi-Square Distribution. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Radiotherapy, Adjuvant. Retrospective Studies. Survival Analysis. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15663837.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Mojica-Manosa P, Rigual N, Tan D, Sullivan M: An unusual case of a metastatic adenocarcinoma of the rectum to the mandible: a case report and review of the literature. J Oral Maxillofac Surg; 2006 Sep;64(9):1436-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of a metastatic adenocarcinoma of the rectum to the mandible: a case report and review of the literature.
  • [MeSH-major] Adenocarcinoma / secondary. Mandibular Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16916682.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 13
  •  go-up   go-down


15. Bellizzi AM, Bloomston M, Bellizzi SM, Marsh WL, Frankel WL: Assessment of prognostic factors in pancreatic ductal adenocarcinoma: Focus on the retroperitoneal margin. J Clin Oncol; 2009 May 20;27(15_suppl):e15670

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of prognostic factors in pancreatic ductal adenocarcinoma: Focus on the retroperitoneal margin.
  • : e15670 Background: Pancreatic ductal adenocarcinoma (PDA) is a leading cause of cancer death in the West, with a nearly superimposable incidence and mortality.
  • At another site with a retroperitoneal margin (i.e. rectum), 1 mm margins are significant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962842.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Carlsson G, Bjökqvist H, Kurlberg G, Torbjörn S, Casillas M, Holmqvist M, Stoffregen C, Gustavsson B: Feasibility of treatment of resectable rectal cancer with neoadjuvant treatment with pemetrexed. J Clin Oncol; 2009 May 20;27(15_suppl):e15121

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Feasibility of treatment of resectable rectal cancer with neoadjuvant treatment with pemetrexed.
  • : e15121 Background: Multimodality strategies of chemo- and radiotherapy (RT) in the neoadjuvant setting of resectable rectal cancer are a challenge to optimize surgery outcome.
  • Pemetrexed (P) has shown efficacy in colorectal cancer.
  • This phase II trial evaluated its feasibility as neo-adjuvant monotherapy for patients (pts) with resectable rectal cancer.
  • METHODS: Between June' 06 and January' 08, 37 pts with a histologically proven diagnosis of operable rectal adenocarcinoma were enrolled.
  • 12 out of 13 planned pts had a rectum amputation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960841.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Gasent Blesa J, Alberola Candel V, Juan O, Provencio Pulla M, Giner Marco V, Gravalos C, Fernandez I, Llorca C: Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial. J Clin Oncol; 2009 May 20;27(15_suppl):e15101

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial.
  • : e15101 Background: Between April 2006 and May 2008, 27 rectal adenocarcinoma pt were included (cT3: 25 pt, T4: 2 pt, N0: 11 Pt, N+: 16 pt), stages II-III, RMN staged, 14 male and 13 female.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964345.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Pinto C, Di Fabio F, Maiello E, Di Tullio P, Pini S, Aschele C, Garufi C, Bochicchio A, Pinotti G, Latiano T, Martoni A: Phase II study of preoperative panitumumab, 5-fluorouracil, and oxaliplatin with concurrent radiotherapy in locally advanced rectal cancer: Preliminary safety results (StarPan /STAR-02 Study). J Clin Oncol; 2009 May 20;27(15_suppl):4110

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase II study of preoperative panitumumab, 5-fluorouracil, and oxaliplatin with concurrent radiotherapy in locally advanced rectal cancer: Preliminary safety results (StarPan /STAR-02 Study).
  • : 4110 Background: The aim of this phase II study is to assess the activity of preoperative external radiotherapy combined with panitumumab, oxaliplatin and 5-fluorouracil in locally advanced rectal cancer patients (pts).
  • METHODS: Pts entering the study had histologically-proven rectal adenocarcinoma, either uT3N+ or T4 N-/+ stage, with location <12 cm from the anal margin.
  • Rectal surgery was performed 7-8 weeks after the end of neoadjuvant treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961230.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Nonaka K, Sha S, Ito M, Nonaka K, Yamanaka N: [A case of poorly differentiated adenocarcinoma of the rectum with disseminated carcinomatosis of the bone marrow successfully treated with mFOLFOX-6/bevacizumab]. Nihon Shokakibyo Gakkai Zasshi; 2010 Jul;107(7):1151-8
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of poorly differentiated adenocarcinoma of the rectum with disseminated carcinomatosis of the bone marrow successfully treated with mFOLFOX-6/bevacizumab].
  • A 45-year-old woman, complaining of back pain and bloody stool was given a diagnosis of poorly differentiated adenocarcinoma of the rectum with disseminated carcinomatosis to bone marrow and disseminated intravascular coagulation syndrome (DIC).
  • Colonoscopy findings showed almost normal rectal mucosa after a total of 10 courses of chemotherapy.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antibodies, Monoclonal / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bone Marrow Neoplasms / drug therapy. Carcinoma / drug therapy. Rectal Neoplasms / drug therapy

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20616483.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Organoplatinum Compounds; 2S9ZZM9Q9V / Bevacizumab; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  • [Number-of-references] 30
  •  go-up   go-down


20. Ohnishi T, Kanoh T, Danno K, Miyazaki S, Kimura Y, Iwazawa T, Tono T, Nakano Y, Yano H, Monden T, Imaoka S: [A complete response of locally-advanced poorly differentiated adenocarcinoma of the rectum to pre-operative chemo-radiation therapy]. Gan To Kagaku Ryoho; 2008 Nov;35(12):2159-61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A complete response of locally-advanced poorly differentiated adenocarcinoma of the rectum to pre-operative chemo-radiation therapy].
  • A 71-year-old woman with peri-anal pain and anal bleeding was found to have a tumor in lower rectum in colonoscopic examination, which was histologically diagnosed as poorly differentiated adenocarcinoma.
  • Poorly differentiated adenocarcinoma of the colon is reported to be highly malignant and associated with poor prognosis.
  • Preoperative chemo-radiation therapy can be a promising candidate for adjuvant treatment of locally-advanced poorly differentiated adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Cell Differentiation. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Aged. Colonoscopy. Female. Humans. Neoadjuvant Therapy. Neoplasm Staging. Remission Induction. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19106556.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


21. Moreno Garcia V, Cejas P, Feliu J, De Castro J, Belda-Iniesta C, Barriuso J, Larrauri J, Gonzalez Baron M, Casado E: Immunohistochemical analysis of tumor regression grade for rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol; 2009 May 20;27(15_suppl):e22089

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical analysis of tumor regression grade for rectal cancer after neoadjuvant chemoradiotherapy.
  • : e22089 Background: Tumor regression grade (TRG) as defined by Rodel et al. has been suggested as an independent prognostic factor for rectal carcinoma patients treated by preoperative chemoradiotherapy (CRT).
  • CONCLUSIONS: The EGFR/CD133 double negative rectal tumors with TRG 2 or 3 after chemoradiotherapy show a higher risk of relapse or death.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963266.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Djellali L, Larbaoui B, Boukerche A, Ghazi S, Chaiba I, Meziane N, Yekrou D, Youcef DF: Preoperative concomitant chemoradiotherapy with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):e15108

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative concomitant chemoradiotherapy with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma.
  • : e15108 Background: Preoperative concomitant chemoradiotherapy has shown to improve local control and sphincter preservation with decreased acute toxicity compared with postoperative treatment in locally advanced rectal carcinoma.
  • Secondary endpoint was sphincter preservation and toxicity Methods: Inclusion criteria: rectal adenocarcinoma <12 cms from anal verge, clinical stage T3-4, adequate renal, hematological and liver function.
  • Main adverse effects (NCI-CTC): diarrhea G3-4: 14.2%, sensitive peripheral neurotoxicity G1: 26.6%, nausea/vomiting G3-4: 11%, Anemia G3-4: 7.1%, neutropenia G3-4: 14.2% Conclusions: Preliminary results show that preoperative concomitant chemoradiotherapy with oxaliplatin and 5FU-folinic acid is an effective regimen with an acceptable safety profile for locally advanced rectal cancer, leading to a high probability of tumor downstaging.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964340.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Lenehan PF, Fry DW, Heyman ER, Eliason JF, Worzel WP: Generation and validation of a primary-tumor-derived four-gene prognostic signature for recurrence (R) of stages I/II colorectal cancer (CRC) following potentially curative resection. J Clin Oncol; 2009 May 20;27(15_suppl):4035

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Generation and validation of a primary-tumor-derived four-gene prognostic signature for recurrence (R) of stages I/II colorectal cancer (CRC) following potentially curative resection.
  • METHODS: Archival formalin-fixed paraffin-embedded (FFPE) primary adenocarcinoma tissues obtained at initial resection with curative intent were retrieved for 145 stage I/II (pT1-4 pN0 M0) CRC pts from multiple international sites; none had neoadjuvant or adjuvant therapy.
  • RR by stage (I/II) = 7.00/7.28 and tumor site (colon/rectum) = 8.75/4.50.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961545.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Comella P, Massidda B, Natale D, Filippelli G, Farris A, Condemi G, Palmeri S, Tafuto S, Vessia G, Barberis G: Bevacizumab (Bev), irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): The SICOG experience. J Clin Oncol; 2009 May 20;27(15_suppl):e15067

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bevacizumab (Bev), irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): The SICOG experience.
  • Fifty-six pts had a colon, and 29 pts a rectal carcinoma.
  • Twenty-one (25%) pts had an unresected primary (colon 13, rectum 8).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964522.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Serra Aracil X, Bombardó Juncá J, Mora López L, Alcantara Moral M, Ayguavives Garnica I, Darnell Marti A, Casalots Casado A, Pericay Pijaume C, Campo Fernández de Los Ríos R, Navarro Soto S: [Site of local surgery in adenocarcinoma of the rectum T2N0M0]. Cir Esp; 2009 Feb;85(2):103-9
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Site of local surgery in adenocarcinoma of the rectum T2N0M0].
  • [Transliterated title] Lugar de la cirugía local en el adenocarcinoma de recto T(2)N(0)M(0).
  • INTRODUCTION: The local exeresis adenocarcinoma of the rectum T(2)N(0)M(0) (ADC-T2), using transanal endoscopic microsurgery (TEM), has the benefit of achieving lower morbidity with a better quality of life.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19231466.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


26. Greenberg HL, Lopez L, Butler DF: Peristomal metastatic adenocarcinoma of the rectum. Arch Dermatol; 2006 Oct;142(10):1372-3
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peristomal metastatic adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Rectal Neoplasms / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Colostomy. Diagnosis, Differential. Female. Humans. Neoplasm Metastasis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17043208.001).
  • [ISSN] 0003-987X
  • [Journal-full-title] Archives of dermatology
  • [ISO-abbreviation] Arch Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


27. Haroon M, Kwong WY, Cantwell B, Walker F: A case of cetuximab-related tumour lysis syndrome in metastatic rectal carcinoma. NDT Plus; 2010 Jun;3(3):271-272

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of cetuximab-related tumour lysis syndrome in metastatic rectal carcinoma.
  • A 60-year-old man was diagnosed with a moderately differentiated adenocarcinoma in November 2006.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2008 May 10;26(14):2406-8 [18467734.001]
  • [Cites] Ann Oncol. 2005 May;16 Suppl 4:iv50-55 [15923430.001]
  • [Cites] J Natl Cancer Inst. 1998 May 6;90(9):675-84 [9586664.001]
  • [Cites] Cancer Res. 2007 Mar 15;67(6):2643-8 [17363584.001]
  • [Cites] J Clin Oncol. 2001 Jan 15;19(2):299-304 [11208819.001]
  • [Cites] Eur J Cancer. 2001 Sep;37 Suppl 4:S16-22 [11597400.001]
  • (PMID = 28657052.001).
  • [ISSN] 1753-0784
  • [Journal-full-title] NDT plus
  • [ISO-abbreviation] NDT Plus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


28. Mezhir JJ, Smith KD, Fichera A, Hart J, Posner MC, Hurst RD: Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery; 2005 Oct;138(4):658-63; discussion 663-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin?
  • BACKGROUND: Preoperative combined-modality therapy (CMT) is considered the treatment approach of choice for rectal cancer.
  • To examine the effect of CMT on distal intramural spread (DIS), we determined the extent of DIS in rectal cancer specimens after CMT.
  • METHODS: Specimens from 20 patients after preoperative CMT and total mesorectal excision for rectal cancer were analyzed for extent of DIS.
  • CONCLUSIONS: Our study shows that the vast majority of patients with rectal cancer after neoadjuvant CMT have no tumor cells beyond 1 cm from the residual tumor.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Combined Modality Therapy. Neoplasm, Residual / pathology. Preoperative Care. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Humans. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Invasiveness. Postoperative Period

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16269294.001).
  • [ISSN] 0039-6060
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Kalteis T, Heers G, Elsner R: Adenocarcinoma of the rectum in childhood following chemotherapy and radiotherapy for a rhabdomyosarcoma--a case report. Eur J Pediatr Surg; 2005 Jun;15(3):210-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma of the rectum in childhood following chemotherapy and radiotherapy for a rhabdomyosarcoma--a case report.
  • We report a case of rectal adenocarcinoma in a 9-year-old boy, which took the form of a second malignant neoplasm following treatment for an early childhood malignancy.
  • At the time of diagnosis of the rectal carcinoma, the tumor had already progressed to the stage of metastatic disease.
  • Therapy consisted of deep anterior rectal resection and regional arterial chemotherapy for liver metastases.
  • The child died 18 months after the diagnosis of rectal carcinoma.
  • As survival for childhood tumors improves, rare second malignant neoplasms will become increasingly common in children and adolescents.
  • The increased risk of second malignant neoplasms and an early onset of adult-type tumors has to be considered.
  • [MeSH-major] Adenocarcinoma / surgery. Neoplasms, Second Primary. Rectal Neoplasms / surgery. Rhabdomyosarcoma, Embryonal / drug therapy. Rhabdomyosarcoma, Embryonal / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15999318.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


30. Bardia A, Greeno E, Miller R, Alberts S, Dozois E, Haddock M, Limburg P: Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis? Colorectal Dis; 2010 Apr;12(4):312-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis?
  • OBJECTIVE: Metastatic involvement of inguinal lymph nodes (ILN) from rectal adenocarcinoma is unusual, particularly without signs of distant spread to other organ sites.
  • METHOD: This case series provides a descriptive report of patients with rectal adenocarcinoma and solitary inguinal lymph node metastasis (SILNM).
  • RESULTS: Upon retrospective review of medical records from 4480 patients with rectal adenocarcinoma seen at Mayo Clinic Rochester from 1995 to 2004, six patients (0.13%) with SILNM were identified.
  • The mean age at SILNM diagnosis was 61.3 years, and three patients had originally stage II (and three had stage III disease).
  • Among those with metachronous SILNM, the mean survival after diagnosis of rectal cancer was 42 months.
  • CONCLUSION: Solitary involvement of ILNs might represent a distinct subset of patients with metastatic rectal adenocarcinoma who have a more favourable prognosis.
  • [MeSH-major] Adenocarcinoma / secondary. Inguinal Canal / pathology. Neoplasms, Multiple Primary / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19250258.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


31. Nano M, Ferronato M, Solej M, D'Amico S: T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Tumori; 2006 Nov-Dec;92(6):469-73
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
  • Although local excision for rectal cancer has been practiced for more than 120 years, its proper use for the cure of localized rectal cancers is still incompletely understood.
  • The stage of the disease at the time of diagnosis is the main prognostic factor in rectal cancer.
  • Today the commonly utilized criteria for local excision of rectal cancer are stage T1N0M0, histological grade G1 or G2, and size 3 to 4 cm.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / surgery. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Age Factors. Anal Canal / surgery. Colectomy / adverse effects. Humans. Lymphatic Metastasis. Microsurgery. Neoplasm Recurrence, Local. Neoplasm Staging. Patient Selection. Proctoscopy. Prognosis. Risk Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17260485.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 59
  •  go-up   go-down


32. Larbaoui B: Preoperative concomitant chemoradiotherapy with capecitabine in locally advanced rectal carcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):e15134

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative concomitant chemoradiotherapy with capecitabine in locally advanced rectal carcinoma.
  • : e15134 Background: Preoperative concomitant chemoradiotherapy has shown to improve local control and sphincter preservation with decreased acute toxicity compared with postoperative treatment in locally advanced rectal carcinoma.
  • METHODS: Inclusion criteria: rectal adenocarcinoma <12 cms from anal verge, clinical stage T3-4, adequate renal, hematological and liver function.
  • CONCLUSIONS: Preliminary results show that preoperative concomitant chemoradiotherapy with Capecitabine is an effective regimen with an acceptable safety profile for locally advanced rectal cancer, leading to a high probability of tumor downstaging.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960909.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Wafa BR, Amel B, Samir A, Mounir BS, Nabil BH, Zeineb M, Mounir F, Chokri C, Mahfoudh A: [Adenocarcinoma of the rectum in a 14-year-old]. Arch Pediatr; 2008 Nov;15(11):1656-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenocarcinoma of the rectum in a 14-year-old].
  • [Transliterated title] Adénocarcinome du rectum chez 1 enfant de 14 ans.
  • Colorectal cancer is rare in children and adolescents.
  • Two familial syndromes are best characterized, hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis.
  • We report the case of a 14-year-old girl having a Dukes D adenocarcinoma of the rectum with peritoneal extension and bone metastases.
  • [MeSH-major] Adenocarcinoma. Rectal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18848439.001).
  • [ISSN] 0929-693X
  • [Journal-full-title] Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
  • [ISO-abbreviation] Arch Pediatr
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


34. Matuschek C, Bölke E, Gripp S, Budach W, Hermsen D, Peiper M: Mediator release during combined radio chemotherapy in rectal carcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):3043

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mediator release during combined radio chemotherapy in rectal carcinoma.
  • Today neoadjuvant chemoradiotherapy is the gold standard for uT3, N+ rectal cancer.
  • The aim of this study was to evaluate if a gut barrier dysfunction occurred during radiotherapy and elective rectal surgery.
  • METHODS: We investigated in 45 patients (25 male, 20 female) with uT3N+ rectal carcinoma and neoadjuvante long-term radio chemotherapy with 5-FU and pelvis irridation up to 50.4 Gy on admission and weekly during radiotherapy and after surgery IL-6, LPS-binding protein, IL-8, TNF-α and procalcitonin.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961978.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Gawkowska-Suwinska M, Fijałkowski M, Białas B, Szlag M, Kellas-Ślęczka S, Nowicka E, Behrendt K, Plewicki G, Smolska-Ciszewska B, Giglok M, Zajusz A, Owczarek G: Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy. J Contemp Brachytherapy; 2009 Dec;1(4):211-215
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy.
  • PURPOSE: The aim of the study was to analyze early effects and toxicity of salvage high dose rate brachytherapy for local recurrences of adenocarcinoma of the prostate after external beam radiotherapy (EBRT).
  • MATERIAL AND METHODS: In MCS Memorial Institute of Oncology in Gliwice a research programme on salvage HDR brachytherapy for local recurrences of prostate cancer treated previously with EBRT has been ongoing since February 2008.
  • Maximal bladder and rectum doses were constrained to be ≤ 70% of the prescribed dose.
  • Only in two patients grade 1 toxicity for rectum was observed.
  • In one patient grade 2 rectal toxicity was observed, and one had urethral stricture.
  • CONCLUSIONS: Salvage brachytherapy for localized prostate cancer (3 × 10 Gy every 14 days) seems to be a safe and well tolerated procedure.
  • A significant decline in prostate-specific antigen (PSA) level is seen in patients with hormone-responsive cancer.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28050174.001).
  • [ISSN] 1689-832X
  • [Journal-full-title] Journal of contemporary brachytherapy
  • [ISO-abbreviation] J Contemp Brachytherapy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  • [Keywords] NOTNLM ; prostate cancer / radiotherapy / recurrences / salvage brachytherapy
  •  go-up   go-down


36. Gupta PJ: Rectal cancer presenting as ischio-rectal abscess and Fournier's gangrene--a case report. Eur Rev Med Pharmacol Sci; 2010 Feb;14(2):139-40
MedlinePlus Health Information. consumer health - Rectal Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal cancer presenting as ischio-rectal abscess and Fournier's gangrene--a case report.
  • We report a case of adenocarcinoma of the rectum where the patient presented with extensive ischio-rectal abscess with Fournier's gangrene.
  • [MeSH-major] Abscess / etiology. Fournier Gangrene / etiology. Rectal Diseases / etiology. Rectal Neoplasms / complications

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Abscess.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20329573.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


37. Wortham AH, Schreiber D, Rineer J, Katsoulakis E, Sroufe R, Marienberg E, Nwokedi E, Han P, Choi K, Rotman M: Overall survival using local excision techniques with and without radiation compared with APR for stage I rectal cancer: A SEER based analysis. J Clin Oncol; 2009 May 20;27(15_suppl):4032

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overall survival using local excision techniques with and without radiation compared with APR for stage I rectal cancer: A SEER based analysis.
  • : 4032 Background: The standard of care for Stage I rectal cancer is radical resection.
  • This analysis compares the outcomes of sphincter sparing treatment with radical surgery in Stage I rectal cancer.
  • METHODS: Using the Surveillance, Epidemiology and End-Results (SEER) registry, we performed a query of patients with Stage T1-2N0 (T=4 cm or less) rectal adenocarcinoma between 1988 and 2003 who were treated with either local excision alone (LE), local excision followed by radiotherapy (LE+RT) or abdominoperineal resection (APR).
  • CONCLUSIONS: According to this analysis, there was no statistical difference in survival for patients with Stage I rectal carcinoma undergoing APR versus LE+RT.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961548.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Savchenko IuP, Polovinkin VV, Fedosov SR, Pryn' PS: [Combination of giant mucocele of the appendix and adenocarcinoma of the rectum]. Khirurgiia (Mosk); 2006;(10):57-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Combination of giant mucocele of the appendix and adenocarcinoma of the rectum].
  • [MeSH-major] Adenocarcinoma / complications. Appendiceal Neoplasms / complications. Mucocele / complications. Rectal Neoplasms / complications
  • [MeSH-minor] Aged. Appendectomy. Biopsy. Colectomy. Diagnosis, Differential. Female. Humans. Severity of Illness Index. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17167911.001).
  • [ISSN] 0023-1207
  • [Journal-full-title] Khirurgiia
  • [ISO-abbreviation] Khirurgiia (Mosk)
  • [Language] rus
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


39. Abächerli C, Metzger J: Single metastasis in the gallbladder arising from adenocarcinoma of the rectum. South Med J; 2008 Nov;101(11):1183-4
MedlinePlus Health Information. consumer health - Gallbladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Single metastasis in the gallbladder arising from adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / pathology. Colorectal Neoplasms / pathology. Gallbladder Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19088539.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


40. Jaksić E, Starović D, Lesić A, Beatović S, Popov M, Kecmanović D: Tc-99m DPD uptake in the thigh from metastasis of adenocarcinoma of the rectum. Clin Nucl Med; 2005 Jan;30(1):51-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tc-99m DPD uptake in the thigh from metastasis of adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Adenocarcinoma / secondary. Diphosphonates. Organotechnetium Compounds. Rectal Neoplasms / radionuclide imaging. Soft Tissue Neoplasms / radionuclide imaging. Soft Tissue Neoplasms / secondary. Thigh / radionuclide imaging
  • [MeSH-minor] Adult. Bone Neoplasms / metabolism. Bone Neoplasms / radionuclide imaging. Bone Neoplasms / secondary. Diagnosis, Differential. Humans. Male. Radiopharmaceuticals / pharmacokinetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15604976.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Diphosphonates; 0 / Organotechnetium Compounds; 0 / Radiopharmaceuticals; 0 / technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid
  •  go-up   go-down


41. Tardío JC, Nájera L, Alemany I, Martín T, Castaño A, Pérez-Regadera JF: Rectal angiosarcoma after adjuvant chemoradiotherapy for adenocarcinoma of the rectum. J Clin Oncol; 2009 Sep 20;27(27):e116-7
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal angiosarcoma after adjuvant chemoradiotherapy for adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / therapy. Hemangiosarcoma / pathology. Neoplasms, Radiation-Induced / pathology. Neoplasms, Second Primary / pathology. Radiotherapy, Adjuvant / adverse effects. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Antimetabolites, Antineoplastic / administration & dosage. Chemotherapy, Adjuvant. Fatal Outcome. Fluorouracil / administration & dosage. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19667271.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


42. Kayaçetin E, Kayaçetin S: Colitis cystica profunda simulating rectal carcinoma. Acta Chir Belg; 2005 May-Jun;105(3):306-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colitis cystica profunda simulating rectal carcinoma.
  • Localized colitis cystica profunda is a rare, benign disease of the lower gastro-intestinal tract, usually presenting as a rectal mass and characterized microscopically by the presence of mucus-filled cysts in the submucosa.
  • Knowledge of this particular pathological entity is important as it can mimic a well differentiated adenocarcinoma of the rectum and therefore could lead to unnecessary surgical resection.
  • We present a case of colitis cystica profunda misdiagnosed as adenocarcinoma based on their similar clinical picture and histological features.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Colitis / diagnosis. Colitis / pathology. Cysts / diagnosis. Cysts / pathology. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16018526.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


43. Kodama K, Mizuno T, Imahori T, Ida M, Matsubara F: Concurrent diagnosis of urothelial carcinoma and squamous cell carcinoma of the bladder in a patient with a vesicorectal fistula from invasive rectal cancer. Int J Urol; 2006 Mar;13(3):296-8
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concurrent diagnosis of urothelial carcinoma and squamous cell carcinoma of the bladder in a patient with a vesicorectal fistula from invasive rectal cancer.
  • A 47-year-old man underwent a low anterior resection of the rectosigmoid colon with en bloc cystoprostatectomy for vesicorectal fistula due to a locally advanced rectal cancer.
  • Histopathological examination of the bladder revealed two additional primary malignancies: urothelial carcinoma and squamous cell carcinoma.
  • To our knowledge, this is the first reported case of two histologically distinct urothelial malignancies that were diagnosed during a work up of vesicorectal fistula due to adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Squamous Cell / diagnosis. Neoplasms, Multiple Primary / diagnosis. Rectal Fistula / etiology. Rectal Neoplasms / diagnosis. Urinary Bladder Fistula / etiology. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Sigmoidoscopy

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Bladder cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16643630.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


44. Skelton MR, Goldberg RM, O'Neil BH: A case of oxaliplatin-related posterior reversible encephalopathy syndrome. Clin Colorectal Cancer; 2007 Jan;6(5):386-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 19-year-old woman with metastatic adenocarcinoma of the rectum received modified FOLFOX (5-fluorouracil/oxaliplatin) chemotherapy.
  • [MeSH-major] Antineoplastic Agents / adverse effects. Brain Diseases / chemically induced. Organoplatinum Compounds / adverse effects. Rectal Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17311705.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin
  •  go-up   go-down


45. Cabassa P, Morone M, Gatti E, Narbone M, Maroldi R: Gardner syndrome complicated with hydronephrosis. A case report. J Radiol Case Rep; 2010;4(3):19-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of a man who was admitted for a relapse of adenocarcinoma of the rectum.
  • CT-staging showed multiple locations of desmoid tumors and osteomas, with final diagnosis of Gardner syndrome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22470715.001).
  • [ISSN] 1943-0922
  • [Journal-full-title] Journal of radiology case reports
  • [ISO-abbreviation] J Radiol Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3303379
  • [Keywords] NOTNLM ; Gardner / computed tomography / desmoid tumors
  •  go-up   go-down


46. Ghosh D, Boama V: Undiagnosed rectal tumour--a rare cause of obstructed labour in the second stage. BMJ Case Rep; 2010;2010
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Undiagnosed rectal tumour--a rare cause of obstructed labour in the second stage.
  • Colorectal cancer presenting in pregnancy is extremely rare.
  • Here the authors present the case of a 25-year-old woman who was diagnosed with second-stage obstructed labour secondary to a large rectal tumour.
  • Histology later confirmed villous adenocarcinoma of the rectum.
  • The patient died from metastatic rectal cancer within 2 years of diagnosis.
  • [MeSH-major] Adenocarcinoma / diagnosis. Cesarean Section. Dystocia / surgery. Pregnancy Complications, Neoplastic / diagnosis. Rectal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Cesarean Section.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Gynaecol Obstet. 1987 Aug;25(4):337-40 [2887470.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1995 Nov;63(1):95-6 [8674574.001]
  • [Cites] Gastroenterol Clin North Am. 1998 Mar;27(1):225-56 [9546092.001]
  • [Cites] Aust N Z J Obstet Gynaecol. 1998 Nov;38(4):474 [9890239.001]
  • [Cites] J Reprod Med. 2007 Jun;52(6):545-7 [17694979.001]
  • [Cites] Arch Gynecol Obstet. 2009 Mar;279(3):427-9 [18665376.001]
  • [Cites] Br J Obstet Gynaecol. 1978 Mar;85(3):231-3 [629904.001]
  • [Cites] Br J Obstet Gynaecol. 1979 Sep;86(9):747-8 [497148.001]
  • [Cites] Dis Colon Rectum. 1981 Sep;24(6):473-5 [7273986.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1985 Nov;20(5):325-8 [3908181.001]
  • (PMID = 22767473.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3030301
  •  go-up   go-down


47. Artioukh DY: Controversial aspects of rectal cancer surgery following preoperative chemoradiation. Colorectal Dis; 2010 Aug;12 Suppl 2:25-9
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Controversial aspects of rectal cancer surgery following preoperative chemoradiation.
  • The role of surgery in the loco-regional control of adenocarcinoma of the rectum is being increasingly challenged by the good response rates of neoadjuvant oncological treatment.
  • This review represents an opinion paper outlining well-established choices and new trends in surgical intervention, unresolved difficulties of local and regional staging of rectal malignancy and accurate assessment of tumour response to preoperative downstaging chemoradiation.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Humans. Neoadjuvant Therapy. Neoplasm Recurrence, Local / prevention & control. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20618364.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


48. Saad-Hossne R, Prado RG, Bakonyi Neto A, Marchezan MA: Peritoneal pseudomyxoma associated with synchronic malignant mucinous neoplasias of the cecum, appendix and rectum. Case report and review of the literature. Acta Cir Bras; 2007 Sep-Oct;22(5):407-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneal pseudomyxoma associated with synchronic malignant mucinous neoplasias of the cecum, appendix and rectum. Case report and review of the literature.
  • We report a peritoneal pseudomyxoma associated with mucinous adenocarcinoma of the appendix synchronic with adenocarcinoma of the rectum in a 44 year old patient, where the initial diagnosis was rectal adenocarcinoma.
  • We focus the histological patterns of the lesions, diagnosis and the treatment, with revision of the literature.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17923963.001).
  • [ISSN] 0102-8650
  • [Journal-full-title] Acta cirurgica brasileira
  • [ISO-abbreviation] Acta Cir Bras
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 33
  •  go-up   go-down


49. Sadahiro S, Suzuki T, Maeda Y, Tanaka A, Kamijo A, Murayama C, Nakayama Y, Akiba T: Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. Anticancer Res; 2010 Mar;30(3):993-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma.
  • BACKGROUND: We previously reported that preoperative chemoradiotherapy (CRT) combined with intraoperative electron irradiation for cT3/T4 adenocarcinoma of the rectum reduced the local recurrence, with significant improvement of survival.
  • PATIENTS AND METHODS: Thirty patients with cT3/T4 adenocarcinoma of the rectum were randomly assigned to 2 weeks' irradiation and 4 weeks' S-1 administration before surgery (control group), or the same CRT with simultaneous 4 weeks' PSK administration (PSK group).
  • [MeSH-major] Adenocarcinoma / immunology. Adenocarcinoma / therapy. Immunologic Factors / therapeutic use. Proteoglycans / therapeutic use. Rectal Neoplasms / immunology. Rectal Neoplasms / therapy

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20393026.001).
  • [ISSN] 1791-7530
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Immunologic Factors; 0 / Proteoglycans; 66455-27-4 / krestin
  •  go-up   go-down


50. Ferrante M, Van Boxelaer I, De Man M, Schelfout AM, Van Molhem Y, Hendrickx K, Vandervoort J, Van Der Spek P, Sermon F, Du Ville L, Lepoutre L: Second primary malignancies in patients with a gastrointestinal neuroendocrine tumour: a case report and review of the literature. Acta Gastroenterol Belg; 2010 Jul-Sep;73(3):397-402
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This review is illustrated by a case report of a patient in whom the radiological diagnosis of a diffuse liver metastasized adenocarcinoma of the rectum changed dramatically after positron emission tomography and explorative laparoscopy to a curable adenocarcinoma of the rectum with a simultaneous well-differentiated neuroendocrine carcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Liver Neoplasms / secondary. Neoplasms, Second Primary / diagnosis. Neuroendocrine Tumors / pathology. Positron-Emission Tomography. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Acta Gastroenterol Belg. 2010 Oct-Dec;73(4):536-7
  • (PMID = 21086947.001).
  • [ISSN] 1784-3227
  • [Journal-full-title] Acta gastro-enterologica Belgica
  • [ISO-abbreviation] Acta Gastroenterol. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Belgium
  •  go-up   go-down


51. Cho SI, Park YH, Cho JH, Ryoo BY, Yang SH, Youn SM, Ko JS: Extraskeletal Ewing's sarcoma of the head and neck presenting as blindness. Korean J Intern Med; 2007 Jun;22(2):133-7
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The final diagnosis was extraskeletal Ewing's sarcoma after biopsy of the internal jugular vein thrombosis by histopathological evaluation and immunohistochemical assay.
  • In addition, the patient was diagnosed as having adenocarcinoma of the rectum by biopsy of the rectal mass.

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • Genetic Alliance. consumer health - Blindness.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Laryngol Otol. 2000 Jan;114(1):73-5 [10789420.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Aug 1;25(15):1996-9 [10908947.001]
  • [Cites] Eur Urol. 2001 May;39(5):613-7 [11464048.001]
  • [Cites] Stroke. 1996 Feb;27(2):243-6 [8571417.001]
  • [Cites] Cancer. 1975 Jul;36(1):240-51 [1203852.001]
  • [Cites] Am J Surg Pathol. 1994 May;18(5):486-94 [7513503.001]
  • [Cites] Am J Pathol. 1995 Dec;147(6):1799-810 [7495304.001]
  • [Cites] Radiology. 1969 Jun;92(7):1501-9 [5799839.001]
  • (PMID = 17616033.001).
  • [ISSN] 1226-3303
  • [Journal-full-title] The Korean journal of internal medicine
  • [ISO-abbreviation] Korean J. Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide
  • [Other-IDs] NLM/ PMC2687615
  •  go-up   go-down


52. Spajić B, Grubisić I, Spajić M, Marusić Z, Demirović A, Mijić A, Kruslin B, Tomas D: Synchronous rectal adenocarcinoma and bilateral clear cell renal carcinoma. Acta Clin Croat; 2010 Jun;49(2):169-72
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous rectal adenocarcinoma and bilateral clear cell renal carcinoma.
  • A 69-year-old man was admitted for resection of rectal adenocarcinoma diagnosed by colonoscopy.
  • Microscopically, rectal adenocarcinoma penetrated the submucosa, without invasion of the muscularis propria.
  • To our knowledge, this is the first case of synchronous adenocarcinoma of the rectum and bilateral clear cell renal cell carcinoma described in the literature to date.
  • [MeSH-major] Adenocarcinoma. Carcinoma, Renal Cell. Kidney Neoplasms. Neoplasms, Multiple Primary. Rectal Neoplasms


53. Saglik Y, Yildiz Y, Basarir K, Tezen E, Güner D: Tumours and tumour-like lesions of the patella: a report of eight cases. Acta Orthop Belg; 2008 Jun;74(3):391-6
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six lesions were primary and two were metastatic, both originating from adenocarcinoma of the rectum.
  • Patients with anterior knee pain related with a tumourous condition usually have significant delay in diagnosis.
  • Further imaging modalities should be used for accurate staging and histological diagnosis of the lesion.
  • [MeSH-major] Bone Neoplasms / diagnosis. Patella
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Child. Female. Humans. Male. Middle Aged. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18686467.001).
  • [ISSN] 0001-6462
  • [Journal-full-title] Acta orthopaedica Belgica
  • [ISO-abbreviation] Acta Orthop Belg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


54. Marwan K, Staples MP, Thursfield V, Bell SW: The rate of abdominoperineal resections for rectal cancer in the state of Victoria, Australia: a population-based study. Dis Colon Rectum; 2010 Dec;53(12):1645-51
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The rate of abdominoperineal resections for rectal cancer in the state of Victoria, Australia: a population-based study.
  • PURPOSE: The aim of this study was to document a population-based rate of abdominoperineal resections for adenocarcinoma of the rectum in the state of Victoria, Australia.
  • METHODS: All resections for adenocarcinoma of the rectum (International Classification of Diseases for Oncology, 3rd edition C20) that were performed in Victoria in the year 2005 were included.
  • Procedures for rectosigmoid or colon cancer were excluded.
  • The sample was taken from the Victorian Cancer Registry.
  • The rate of abdominoperineal resections was calculated by dividing the total number of abdominoperineal resections by the total number of procedures for rectal cancer.
  • The rate of abdominoperineal resections for low rectal cancers was lower (42.8%) among surgeons who had specialist colorectal training compared with those who did not (60.6%) (OR = 2.06; 95% CI, 1.24-3.42).
  • Patients with low rectal cancer operated on by surgeons who had had specialist colorectal training were significantly less likely to undergo an abdominoperineal resection compared with patients undergoing an operation by surgeons who did not have specialist colorectal training.
  • [MeSH-major] Adenocarcinoma / surgery. Digestive System Surgical Procedures / methods. Practice Patterns, Physicians' / statistics & numerical data. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21178859.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Smud D, Augustin G, Kekez T, Kinda E, Majerovic M, Jelincic Z: Gardner's syndrome: genetic testing and colonoscopy are indicated in adolescents and young adults with cranial osteomas: a case report. World J Gastroenterol; 2007 Jul 28;13(28):3900-3
Genetic Alliance. consumer health - Young syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Restorative procto-colectomy and ileal pouch anal anastomosis was made but histology delineated adenocarcinoma of the rectum (Dukes C stage).
  • We conclude that cranial osteomas often precede gastrointestinal manifestations of familial adenomatous polyposis or Gardner's syndrome and such patients should be evaluated with genetic testing followed by colonoscopy if results are positive to prevent the development of colorectal carcinoma.
  • If the diagnosis is positive all family members should be evaluated for familial adenomatous polyposis.
  • [MeSH-major] Gardner Syndrome / diagnosis. Osteoma / congenital. Skull Neoplasms / congenital

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17657852.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4611230
  •  go-up   go-down


56. McLeod HL, Myerson RJ, Zehnbauer B, Trinkaus K, Malyapa RS, Mutch MG, Abbey EE, Alyasiry A, Fleshman JW, Tan BR: TYMS genotype-directed neoadjuvant chemoradiation for rectal cancer. J Clin Oncol; 2009 May 20;27(15_suppl):4028

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] TYMS genotype-directed neoadjuvant chemoradiation for rectal cancer.
  • : 4028 Background: Downstaging (DS) of rectal cancers is achieved in 45% of pts with neoadjuvant 5FU and radiation (XRT).
  • We conducted a prospective single-institution Phase II study using TYMS genotyping to direct neoadjuvant chemoRT for pts with rectal cancer.
  • METHODS: Pts with T3/ T4, N0-2, M0-1 rectal adenocarcinoma staged with transrectal ultrasound (TRUS) or CT/MRI are eligible.
  • CONCLUSIONS: This is the first study to prospectively use TYMS genotyping to direct neoadjuvant chemoXRT in pts with rectal cancer.
  • These results are encouraging for the conduct of a randomized study of genotype-guided neoadjuvant therapy for locally advanced rectal cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961521.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Nogue M, Salud A, Vicente P, Pericay C, Arriví A, Roca JM, Losa F, Ponce J, Safont MJ, Guasch I: Addition of bevacizumab to induction plus concomitant capecitabine-oxaliplatin (XELOX) chemoradiotherapy (CRT) in MRI poor prognosis locally advanced rectal cancer: Avacross study. J Clin Oncol; 2009 May 20;27(15_suppl):4100

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Addition of bevacizumab to induction plus concomitant capecitabine-oxaliplatin (XELOX) chemoradiotherapy (CRT) in MRI poor prognosis locally advanced rectal cancer: Avacross study.
  • : 4100 Background: Concomitant CRT with 5-FU followed 6-8 weeks later by TME surgery is well accepted standard treatment for locally advancer rectal cancer.
  • METHODS: Eligible patients (pts) had high-risk rectal adenocarcinoma defined by MRI: distal T3 at/below levators, T3 at any other level within 2 mm of mesorectal fascia, resectable T4 and any T3 with nodal metastases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961205.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Peng J, Lu JJ, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S: Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Cancer J; 2008 Jan-Feb;14(1):54-61
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
  • BACKGROUND: The purpose of this study was to investigate the significance of CD44 variant 6 (CD44v6) in predicting the treatment outcome of locally advanced adenocarcinoma of the rectum after total mesorectal excision (TME).
  • METHODS: Expression of CD44v6 protein was detected using immunohistochemistry in 179 patients with pathologically confirmed stage II or III rectal adenocarcinoma.
  • CD44v6 is significantly associated with locoregional recurrence in stage III rectal cancer (hazard ratio 6.02, 95% confidence interval 1.25-29.0; P = 0.018), and the overall locoregional recurrence was significantly higher for patients with positive expression of CD44v6 than for those with negative expression (17.63% vs 6.62%; P = 0.026).
  • CONCLUSION: CD44v6 expression in cancer cells is a sensitive marker for predicting the treatment outcome in patients with stage II and III adenocarcinoma of the rectum after TME and may be used to determine the necessity of adjuvant treatment.
  • [MeSH-major] Adenocarcinoma / immunology. Adenocarcinoma / surgery. Antigens, CD44 / analysis. Biomarkers, Tumor / analysis. Glycoproteins / analysis. Neoplasm Recurrence, Local / immunology. Rectal Neoplasms / immunology. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prognosis. Prospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18303484.001).
  • [ISSN] 1528-9117
  • [Journal-full-title] Cancer journal (Sudbury, Mass.)
  • [ISO-abbreviation] Cancer J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Biomarkers, Tumor; 0 / CD44v6 antigen; 0 / Glycoproteins
  •  go-up   go-down


59. Suzuki T, Sakaguchi H, Yamamoto S, Hisa Y: Sudden hearing loss due to meningeal carcinomatosis from rectal carcinoma. Auris Nasus Larynx; 2006 Sep;33(3):315-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sudden hearing loss due to meningeal carcinomatosis from rectal carcinoma.
  • We present a case of meningeal carcinomatosis with bilateral hearing loss secondary to a rectal adenocarcinoma.
  • A 60-year-old woman developed progressive loss of hearing in the left ear 19 months after an abdominoperineal resection for an adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / secondary. Ear Neoplasms / complications. Hearing Loss, Sensorineural / etiology. Hearing Loss, Sudden / etiology. Meningeal Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16413982.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


60. Sakellaridis T, Mathioulakis S, Antiochos C: Synchronous early primary adenocarcinoma of both rectum and gallbladder. Report of a case. Int Semin Surg Oncol; 2005 Sep 14;2:19

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous early primary adenocarcinoma of both rectum and gallbladder. Report of a case.
  • BACKGROUND: Synchronous early primary cancers are rare and in addition synchronous adenocarcinoma of both rectum and gallbladder is extremely rare.
  • CASE REPORT: We report an unusual case of synchronous early primary adenocarcinoma of rectum and gallbladder.
  • An endoscopy revealed adenocarcinoma of the lower rectum.
  • The histopathological diagnosis was well to middle differentiate adenocarcinoma of the gallbladder (T2, N0, M0; stage II) and middle differentiate adenocarcinoma of the rectum (T2, N0, M0; stage II).
  • CONCLUSION: For the cases of extracolonic primary cancer associated with colorectal primary carcinoma, Warren and Gates' diagnostic criteria are used.
  • All patients with colorectal carcinoma, should undergo a throughout preoperative examination to exclude the possibility of synchronous early primary cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chir Ital. 2001 Jan-Feb;53(1):133-9 [11280822.001]
  • [Cites] Asian J Surg. 2003 Jan;26(1):46-8; discussion 49 [12527496.001]
  • [Cites] Jpn J Cancer Res. 1987 Mar;78(3):242-50 [3106280.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 1997 Jun;94(6):440-4 [9216227.001]
  • [Cites] Gan No Rinsho. 1985 Nov;31(14):1849-53 [4087393.001]
  • [Cites] Srp Arh Celok Lek. 1965 Mar;93(3):323-7 [5861499.001]
  • [Cites] Ann Surg. 1982 Apr;195(4):501-7 [7065754.001]
  • [Cites] Klin Wochenschr. 1988 Nov 1;66(21):1093-6 [3236758.001]
  • (PMID = 16162293.001).
  • [ISSN] 1477-7800
  • [Journal-full-title] International seminars in surgical oncology : ISSO
  • [ISO-abbreviation] Int Semin Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1236954
  •  go-up   go-down


61. Abdelrazeq AS, Lund JN, Leveson SH: Spontaneous regression of peritoneal carcinomatosis from a rectal cancer. Eur J Gastroenterol Hepatol; 2005 Dec;17(12):1421-3
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous regression of peritoneal carcinomatosis from a rectal cancer.
  • Here, we present the case of a 51-year-old man who underwent a curative resection for an adenocarcinoma of the rectum in 1989.
  • Biopsies from the peritoneal lesions showed features typical of metastatic adenocarcinoma.
  • A review of the literature revealed two cases of spontaneous regression of peritoneal carcinomatosis secondary to a rectal cancer; we report the third case and discuss some of the reasons potentially responsible for the regression.
  • [MeSH-major] Adenocarcinoma / secondary. Neoplasm Regression, Spontaneous. Peritoneal Neoplasms / secondary. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16292100.001).
  • [ISSN] 0954-691X
  • [Journal-full-title] European journal of gastroenterology & hepatology
  • [ISO-abbreviation] Eur J Gastroenterol Hepatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


62. Mahmalji W, Mackenzie H, Chopada A, Raza A: A novel use for the rigid cystoscope: the removal of sacral tacks after a coloanal anastamosis dehiscence. Adv Urol; 2009;:978038

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She subsequently developed fresh rectal bleeding and after further investigations a Dukes B adenocarcinoma of the rectum was found.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Colorectal Dis. 2004 Nov;19(6):569-73 [15103489.001]
  • [Cites] Colorectal Dis. 2005 Jan;7(1):47-50 [15606584.001]
  • (PMID = 19197375.001).
  • [ISSN] 1687-6369
  • [Journal-full-title] Advances in urology
  • [ISO-abbreviation] Adv Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2633451
  •  go-up   go-down


63. Cercato MC, Colella E, Ferraresi V, Diodoro MG, Tonachella R: Report of two cases of quintuple primary malignancies and review of the literature. Anticancer Res; 2008 Sep-Oct;28(5B):2953-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple primary malignant neoplasms (MPMN) are not uncommon, however, finding more than three primary malignancies in one individual is unusual.
  • Two patients surviving five primary malignant neoplasms for 12 and 18 years are reported: a 55-year-old woman with a squamous cell carcinoma of the larynx, two carcinomas of the breast, a carcinoma of the kidney and an adenocarcinoma of the colon, and a 75-year-old woman with a sarcoma of the myometrium, a carcinoma of the thyroid, an adenocarcinoma of the rectum, a leiomyosarcoma of the colon and a bronchial carcinoid.
  • Relevant features were that colon cancer was quite often present more than once and survival was longer than expected for the stage (median overall survival, 20 years; 95% confidence interval: 12-28 years).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031939.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


64. Colonias A, Farinash L, Miller L, Jones S, Medich DS, Greenberg L, Miller R, Parda DS: Multidisciplinary treatment of synchronous primary rectal and prostate cancers. Nat Clin Pract Oncol; 2005 May;2(5):271-4; quiz 1 p following 274
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
  • BACKGROUND: A 58-year-old Caucasian man with a history of irritable bowel syndrome and occasional rectal bleeding presented with a 4-week history of progressive, bright red blood per rectum.
  • A digital rectal examination revealed a 3 cm distal, midrectal mass.
  • INVESTIGATIONS: Digital rectal examination, colonoscopy, rectal mass biopsy, endorectal ultrasound, transrectal ultrasound-guided prostate biopsy, CT scan and MRI.
  • DIAGNOSIS: Clinical stage III (T3N1M0), moderately differentiated adenocarcinoma of the rectum and clinical stage II (T1cN0M0) adenocarcinoma of the prostate.
  • [MeSH-major] Adenocarcinoma / pathology. Neoplasms, Multiple Primary / pathology. Prostatic Neoplasms / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Antineoplastic Agents, Hormonal / therapeutic use. Combined Modality Therapy. Diagnosis, Differential. Gastrointestinal Hemorrhage / etiology. Humans. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16264963.001).
  • [ISSN] 1743-4254
  • [Journal-full-title] Nature clinical practice. Oncology
  • [ISO-abbreviation] Nat Clin Pract Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal
  •  go-up   go-down


65. Chan R, Reddy M, Freeman DH: Correlation of different 5-FU regimens and time to surgery with pathological complete response in locally advanced rectal cancer patients treated by pre-operative chemo-radiation. J La State Med Soc; 2005 Jul-Aug;157(4):196-201
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of different 5-FU regimens and time to surgery with pathological complete response in locally advanced rectal cancer patients treated by pre-operative chemo-radiation.
  • The best pre-operative chemo-radiation regimen has still to be defined for patients with rectal cancer.
  • We retrospectively performed a study comprised of 26 patients with T3/4 adenocarcinoma of the rectum.
  • [MeSH-major] Antimetabolites, Antineoplastic / administration & dosage. Fluorouracil / administration & dosage. Neoadjuvant Therapy. Rectal Neoplasms / drug therapy. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16250369.001).
  • [ISSN] 0024-6921
  • [Journal-full-title] The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
  • [ISO-abbreviation] J La State Med Soc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


66. Hoshino S, Yamauchi Y, Mikami K, Shinohara T, Noritomi T, Yamashita Y, Maekawa T, Shirakusa T: Does a correlation exist between tumor occupation rate and Dukes classification in rectal cancer? Int Surg; 2007 May-Jun;92(3):133-7
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does a correlation exist between tumor occupation rate and Dukes classification in rectal cancer?
  • This study was undertaken to evaluate the correlation between tumor occupation rate and stage in rectal cancer patients.
  • 210 patients with histologically confirmed adenocarcinoma of the rectum were evaluated.
  • [MeSH-major] Adenocarcinoma / classification. Adenocarcinoma / pathology. Rectal Neoplasms / classification. Rectal Neoplasms / pathology
  • [MeSH-minor] Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging / methods. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17972467.001).
  • [ISSN] 0020-8868
  • [Journal-full-title] International surgery
  • [ISO-abbreviation] Int Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


67. Dyson T, Draganov PV: Squamous cell cancer of the rectum. World J Gastroenterol; 2009 Sep 21;15(35):4380-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Squamous cell cancer of the rectum.
  • Squamous cell carcinoma of the rectum is a rare malignancy.
  • The clear association seen between Human Papilloma Virus and various squamous cancers has not been firmly established for the squamous cell cancer of the rectum.
  • Diagnosis relies on endoscopic examination with biopsy of the lesion.
  • Distinction from squamous cell cancer of the anus can be difficult, but can be facilitated by immunohistochemical staining for cytokeratins.
  • Staging of the cancer with endoscopic ultrasound and computed tomography provides essential information on prognosis and can guide therapy.
  • Squamous cell carcinoma of the rectum is a distinct entity and it is of crucial importance for the practicing Gastroenterologist to be thoroughly familiar with this disease.
  • Compared to adenocarcinoma of the rectum and squamous cell cancer of the anal canal, squamous cell carcinoma of the rectum has different epidemiology, etiology, pathogenesis, and prognosis but, most importantly, requires a different therapeutic approach.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Rectal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endoscopy. 2008 Sep;40 Suppl 2:E45-6 [18300203.001]
  • [Cites] Eur J Cancer. 2008 Nov;44(16):2340-3 [18707873.001]
  • [Cites] Colorectal Dis. 2009 Feb;11(2):191-7 [18462236.001]
  • [Cites] Br J Surg. 1968 Apr;55(4):273-6 [5644391.001]
  • [Cites] JAMA. 1970 Jun 1;212(9):1511-3 [5467545.001]
  • [Cites] Cancer. 1971 Nov;28(5):1111-7 [5125659.001]
  • [Cites] Am J Surg Pathol. 1978 Mar;2(1):47-54 [637188.001]
  • [Cites] J Pathol. 1979 Nov;129(3):139-47 [529012.001]
  • [Cites] Cancer. 1981 Feb 1;47(3):602-9 [7226009.001]
  • [Cites] Dis Colon Rectum. 1981 May-Jun;24(4):301-4 [7238241.001]
  • [Cites] Dis Colon Rectum. 1983 Mar;26(3):188-91 [6825528.001]
  • [Cites] Dis Colon Rectum. 1983 Apr;26(4):279-82 [6839899.001]
  • [Cites] Vopr Onkol. 1984;30(8):76-83 [6485288.001]
  • [Cites] Dis Colon Rectum. 2000 Mar;43(3):338-45 [10733115.001]
  • [Cites] Gastrointest Endosc. 2000 Nov;52(5):683-5 [11060201.001]
  • [Cites] Gastroenterology. 2001 Mar;120(4):988-94 [11231953.001]
  • [Cites] Dis Colon Rectum. 2001 Mar;44(3):341-6 [11289278.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 May;19(5):719-20 [11343961.001]
  • [Cites] Pathology. 2001 Aug;33(3):312-4 [11523931.001]
  • [Cites] Int J Dermatol. 2001 Jun;40(6):373-9 [11589741.001]
  • [Cites] Dis Colon Rectum. 2002 Jun;45(6):733-42; discussion 742-3 [12072622.001]
  • [Cites] Eur J Surg Oncol. 2002 Sep;28(6):657-60 [12359204.001]
  • [Cites] Hematol Oncol Clin North Am. 2002 Aug;16(4):897-906 [12418054.001]
  • [Cites] Dis Colon Rectum. 2002 Nov;45(11):1535-40 [12432303.001]
  • [Cites] Clin Colorectal Cancer. 2001 May;1(1):55-8 [12445380.001]
  • [Cites] Clin Colorectal Cancer. 2002 Feb;1(4):243-8 [12450423.001]
  • [Cites] J Urol. 2003 Jan;169(1):280 [12478160.001]
  • [Cites] Clin Colorectal Cancer. 2004 Jul;4(2):124-32 [15285819.001]
  • [Cites] Arch Pathol. 1967 Jul;84(1):77-80 [6027742.001]
  • [Cites] Dis Colon Rectum. 1967 Jul-Aug;10(4):288-97 [6037409.001]
  • [Cites] Dis Colon Rectum. 1984 Dec;27(12):763-6 [6499614.001]
  • [Cites] Dis Colon Rectum. 1985 Dec;28(12):967-72 [4064861.001]
  • [Cites] J Surg Oncol. 1987 Jun;35(2):117-9 [3586681.001]
  • [Cites] Dis Colon Rectum. 1987 Jul;30(7):495-502 [3109860.001]
  • [Cites] Eur J Surg Oncol. 1987 Oct;13(5):455-8 [3666162.001]
  • [Cites] Dis Colon Rectum. 1988 Mar;31(3):228-35 [3280272.001]
  • [Cites] Dis Colon Rectum. 1988 Apr;31(4):323-6 [3282843.001]
  • [Cites] APMIS. 1988 Sep;96(9):839-44 [3166810.001]
  • [Cites] J Natl Cancer Inst. 1989 Jun 7;81(11):850-6 [2724350.001]
  • [Cites] Dis Colon Rectum. 1989 Jul;32(7):593-9 [2737060.001]
  • [Cites] Scand J Gastroenterol. 1989 Dec;24(10):1243-7 [2513640.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1221-3 [2254116.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1115-25 [1938508.001]
  • [Cites] Int J Colorectal Dis. 1992 Sep;7(3):144-7 [1402312.001]
  • [Cites] Dis Colon Rectum. 1993 Feb;36(2):127-34 [8425415.001]
  • [Cites] Gastrointest Endosc. 1994 Jul-Aug;40(4):442-6 [7926534.001]
  • [Cites] South Med J. 1996 Sep;89(9):921-4 [8790320.001]
  • [Cites] J Clin Oncol. 1996 Sep;14(9):2527-39 [8823332.001]
  • [Cites] Lancet. 1996 Oct 19;348(9034):1049-54 [8874455.001]
  • [Cites] Dis Colon Rectum. 1996 Nov;39(11):1265-8 [8918436.001]
  • [Cites] Rev Invest Clin. 1996 Nov-Dec;48(6):453-6 [9028152.001]
  • [Cites] J Clin Oncol. 1997 May;15(5):2040-9 [9164216.001]
  • [Cites] Dis Colon Rectum. 1999 Jan;42(1):102-9 [10211528.001]
  • [Cites] Gastroenterology. 1958 May;34(5):809-39 [13538148.001]
  • [Cites] Gastroenterology. 1960 Oct;39:385-93 [13686938.001]
  • [Cites] Am J Gastroenterol. 1962 Jan;37:48-54 [14006818.001]
  • [Cites] Dis Colon Rectum. 1963 Sep-Oct;6:370-3 [14063163.001]
  • [Cites] Mayo Clin Proc. 1964 Apr;39:249-51 [14141997.001]
  • [Cites] J Pathol Bacteriol. 1955 Jul;70(1):205-12 [13272134.001]
  • [Cites] Br J Surg. 1965 Sep;52:666-8 [14338313.001]
  • [Cites] Eur J Cancer Care (Engl). 2005 Mar;14(1):70-4 [15698388.001]
  • [Cites] Pathology. 2006 Feb;38(1):74-6 [16484015.001]
  • [Cites] Int J Colorectal Dis. 2007 Apr;22(4):445-7 [16932927.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):919-25 [17527081.001]
  • [Cites] Dis Colon Rectum. 2007 Sep;50(9):1393-400 [17661147.001]
  • [Cites] Eur J Surg Oncol. 2008 Jan;34(1):42-8 [17905562.001]
  • [Cites] JAMA. 2008 Apr 23;299(16):1914-21 [18430910.001]
  • (PMID = 19764088.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic
  • [Number-of-references] 76
  • [Other-IDs] NLM/ PMC2747057
  •  go-up   go-down


68. Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE: Do supervised colorectal trainees differ from consultants in terms of quality of TME surgery? Colorectal Dis; 2006 Nov;8(9):790-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The quality of surgical excision is held to be a major determinant of outcome following surgery for rectal cancer.
  • METHOD: A total of 130 consecutive patients undergoing potentially curative resection for primary adenocarcinoma of the rectum in our centre from 2001 to 2003 were included in the study.
  • CONCLUSION: We conclude that the quality of rectal cancer excision, as defined by mesorectal grades, achieved by supervised colorectal trainees is comparable with that achieved by consultants.
  • [MeSH-major] Clinical Competence. Digestive System Surgical Procedures / standards. Internship and Residency. Quality of Health Care. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Female. Great Britain. Humans. Male. Neoplasm Recurrence, Local. Rectum / anatomy & histology. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17032327.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


69. Fucini C, Pucciani F, Elbetti C, Gattai R, Russo A: Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard? World J Surg; 2010 Jul;34(7):1609-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard?
  • BACKGROUND: Preoperative chemoradiation followed by total mesorectal excision (TME) has become a standard treatment of preoperatively staged T3 low rectal cancers in many institutions; however, a direct comparison of generalized preoperative versus selective adjuvant chemoradiation has never been assessed in a clinical practice setting.
  • PATIENTS: Over a 4-year period, 80 patients with T3 primary low adenocarcinoma of the rectum, judged operable at preoperative staging, were offered preoperative chemoradiation.
  • CONCLUSIONS: In T3 operable low rectal cancers, selective postoperative radiochemotherapy yielded similar long-term results regarding recurrence rate and survival as extended preoperative chemoradiation.
  • [MeSH-major] Adenocarcinoma / surgery. Neoadjuvant Therapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Humans. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Postoperative Complications / epidemiology. Radiotherapy Dosage. Radiotherapy, Adjuvant

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20213202.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


70. Chuang LC, Chen HC, You SL, Lin CY, Pan MH, Chou YC, Hsieh CY, Chen CJ: Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan. Cancer Causes Control; 2010 Dec;21(12):2123-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan.
  • This study aimed at assessing the association between the type-specific human papillomavirus (HPV) infection and the risk of adenocarcinoma of the rectum and recto-sigmoid junction.
  • Newly developed adenocarcinomas of rectum and recto-sigmoid junction were ascertained through computerized linkage with national cancer registry profiles.
  • An increased risk of adenocarcinomas of the rectum and recto-sigmoid junction was observed with HPV infection, showing a hazard ratio [HR] (95% confidence interval [CI]) of 1.99 (0.98-4.04) after adjustment for age and body mass index.
  • Women with cervical infection of HPV types other than 6 and 11 at study entry may have an increased risk of adenocarcinomas of the rectum and recto-sigmoid junction, which deserves further validation by large-scale studies.
  • [MeSH-major] Adenocarcinoma / epidemiology. Papillomavirus Infections / epidemiology. Rectal Neoplasms / epidemiology
  • [MeSH-minor] Adult. Aged. Algorithms. Alphapapillomavirus / physiology. Cohort Studies. Colon, Sigmoid / pathology. Female. Humans. Middle Aged. Rectum / pathology. Taiwan / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20721617.001).
  • [ISSN] 1573-7225
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


71. Eglinton T, Luck A, Bartholomeusz D, Varghese R, Lawrence M: Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer. Colorectal Dis; 2010 Jul;12(7):667-73
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer.
  • OBJECTIVE: The aim of this study was to assess the role of (18)flourodeoxyglucose positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal adenocarcinoma.
  • METHOD: A total of 20 patients with adenocarcinoma of the rectum were assessed with both PET/CT and conventional staging (CT chest/abdomen/pelvis, MRI rectum).
  • Discordance with conventional imaging and incidental findings on PET were recorded and the patients presented to a colorectal cancer multidisciplinary team to assess management changes.
  • CONCLUSION: Positron-emission tomography/computed tomography provides additional information to conventional staging in primary rectal cancer.
  • [MeSH-major] Neoplasm Staging / methods. Positron-Emission Tomography / methods. Rectal Neoplasms / radionuclide imaging. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19486092.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


72. Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J: Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys; 2006 Mar 1;64(3):709-16
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
  • METHODS AND MATERIALS: A total of 134 patients with adenocarcinoma of the rectum (clinical T3/T4 or N1/N2) were treated.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Fluorouracil / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Chemotherapy, Adjuvant. Disease-Free Survival. Female. Humans. Male. Maximum Tolerated Dose. Middle Aged. Neoplasm Recurrence, Local. Postoperative Complications / etiology. Prospective Studies. Radiotherapy Dosage. Radiotherapy, Adjuvant / adverse effects. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16242252.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


73. Szynglarewicz B, Matkowski R, Gisterek I, Forgacz J, Lacko A, Pudelko M, Kornafel J: The impact of pre- or postoperative radiochemotherapy on complication following anterior resection with en bloc excision of female genitalia for T4 rectal cancer. Colorectal Dis; 2009 May;11(4):377-81
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of pre- or postoperative radiochemotherapy on complication following anterior resection with en bloc excision of female genitalia for T4 rectal cancer.
  • OBJECTIVE: The aim of the study was to assess the mortality and morbidity following extended anterior resection with excision of internal female genitalia combined with pre- or postoperative chemoradiotherapy in women with extensive rectal cancer.
  • METHOD: The study included a consecutive series of 21 women with T4 adenocarcinoma of the rectum infiltrating the reproductive organs treated with curative intent between 1997 and 2003.
  • All patients had an extended anterior sphincter preserving resection of the rectum (total mesorectal excision) and hysterectomy with or without posterior vaginal wall excision.
  • [MeSH-major] Adenocarcinoma / therapy. Digestive System Surgical Procedures / methods. Rectal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637920.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


74. Petersen S, Hellmich G, von Mildenstein K, Porse G, Ludwig K: Is surgery-only the adequate treatment approach for T2N0 rectal cancer? J Surg Oncol; 2006 Apr 1;93(5):350-4
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is surgery-only the adequate treatment approach for T2N0 rectal cancer?
  • BACKGROUND AND OBJECTIVES: Resection combined with standard lymphadenectomy is generally recommended for T2N0 rectal cancer.
  • METHODS: To evaluate the results of patients with curative resected T2N0 rectal carcinoma, we reviewed data of 164 consecutive patients with adenocarcinoma of the rectum between 1981 and 2003 in our department.
  • In addition, patient characteristics were stratified according to the position of the rectal tumor with respect to the anal verge.
  • Regarding the tumor localization nearly no local recurrence or distant metastases were observed in the middle or the upper rectum.
  • However, in the lower rectum the actuarial 5-year recurrence rate was 16.2%.
  • CONCLUSIONS: Although T2N0 rectal carcinomas are considered as low risk tumors, we found a considerable local recurrence rate of 3.7%.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Aged, 80 and over. Analysis of Variance. Chemotherapy, Adjuvant. Female. Follow-Up Studies. Germany / epidemiology. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Radiotherapy, Adjuvant. Survival Rate

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16550556.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Endreseth BH, Romundstad P, Myrvold HE, Hestvik UE, Bjerkeset T, Wibe A, Norwegian Rectal Cancer Group: Rectal cancer in the young patient. Dis Colon Rectum; 2006 Jul;49(7):993-1001
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal cancer in the young patient.
  • PURPOSE: The purpose of this national study was to evaluate the results of treatment for young rectal cancer patients.
  • METHODS: This prospective study from the Norwegian Rectal Cancer Project includes all 2,283 patients younger than aged 70 years with adenocarcinoma of the rectum from November 1993 to December 1999.
  • CONCLUSIONS: Patients younger than aged 40 years had a more advanced stage at the time of diagnosis and poor prognosis compared with older patients.
  • [MeSH-major] Adenocarcinoma / therapy. Rectal Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Analysis of Variance. Colectomy. Combined Modality Therapy / methods. Disease-Free Survival. Female. Humans. Male. Middle Aged. Multivariate Analysis. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Norway / epidemiology. Prognosis. Proportional Hazards Models. Prospective Studies. Survival Analysis. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16741599.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Tatli S, Mortele KJ, Breen EL, Bleday R, Silverman SG: Local staging of rectal cancer using combined pelvic phased-array and endorectal coil MRI. J Magn Reson Imaging; 2006 Apr;23(4):534-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Local staging of rectal cancer using combined pelvic phased-array and endorectal coil MRI.
  • PURPOSE: To assess the accuracy of MRI, using a pelvic phased-array coil and an endorectal coil, for preoperative local staging of rectal cancer.
  • MATERIALS AND METHODS: Fifty-one patients (26 males and 25 females) with adenocarcinoma of the rectum underwent preoperative MRI and surgical resection of their tumors.
  • [MeSH-major] Adenocarcinoma / pathology. Magnetic Resonance Imaging / methods. Neoplasm Staging / methods. Rectal Neoplasms / pathology

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2006 Wiley-Liss, Inc.
  • (PMID = 16523466.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Wolberink SV, Beets-Tan RG, de Haas-Kock DF, Span MM, van de Jagt EJ, van de Velde CJ, Wiggers T: Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Dig Dis; 2007;25(1):80-5
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer.
  • PURPOSE: To determine the accuracy of conventional computed tomography (CT) scan in the preoperative prediction of an involved circumferential resection margin (CRM) in primary rectal cancer.
  • METHODS: 125 patients with biopsy-proven adenocarcinoma of the rectum underwent CT of the abdomen before undergoing total mesorectal excision.
  • CONCLUSION: Conventional CT scan lacks sensitivity for a clinical use in the preoperative assessment of an involved CRM in primary rectal cancer.
  • [MeSH-major] Rectal Neoplasms / radiography. Rectal Neoplasms / surgery. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Staging. ROC Curve. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2007 S. Karger AG, Basel.
  • (PMID = 17384512.001).
  • [ISSN] 0257-2753
  • [Journal-full-title] Digestive diseases (Basel, Switzerland)
  • [ISO-abbreviation] Dig Dis
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


78. De Broux E, Parc Y, Rondelli F, Dehni N, Tiret E, Parc R: Sutured perineal omentoplasty after abdominoperineal resection for adenocarcinoma of the lower rectum. Dis Colon Rectum; 2005 Mar;48(3):476-81; discussion 481-2
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sutured perineal omentoplasty after abdominoperineal resection for adenocarcinoma of the lower rectum.
  • PURPOSE: This study was designed to describe and evaluate the efficacy of sutured perineal omentoplasty on perineal wound healing after abdominoperineal resection for adenocarcinoma of the lower rectum.
  • METHODS: Charts of patients who underwent abdominoperineal resection for adenocarcinoma of the rectum from June 1995 to December 2001 were reviewed for mortality, morbidity, and perineal healing.
  • CONCLUSIONS: This study demonstrated that sutured perineal omentoplasty is possible in the majority of patients after abdominoperineal resection for adenocarcinoma of the lower rectum with excellent primary perineal wound healing.
  • [MeSH-major] Adenocarcinoma / surgery. Omentum / surgery. Postoperative Complications. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15714245.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Eriksen MT, Wibe A, Hestvik UE, Haffner J, Wiig JN, Norwegian Rectal Cancer Group, Norwegian Gastrointestinal Cancer Group: Surgical treatment of primary locally advanced rectal cancer in Norway. Eur J Surg Oncol; 2006 Mar;32(2):174-80
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of primary locally advanced rectal cancer in Norway.
  • AIMS: Most reports on locally advanced rectal cancer come from specialized centres, with a selected patient material.
  • The purpose of this study was to examine the results after surgical treatment of patients with locally advanced rectal cancer at a population level.
  • METHODS: National cohort study of 896 patients undergoing surgery for a locally advanced primary adenocarcinoma of the rectum from November 1993 to December 2001.
  • [MeSH-major] Adenocarcinoma / surgery. Digestive System Surgical Procedures. Neoplasm Recurrence, Local. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Cohort Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Multivariate Analysis. Neoplasm Invasiveness. Neoplasm Staging. Norway / epidemiology. Radiotherapy, Adjuvant. Sex Factors. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16412603.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


80. Vesić S, Daković Z, Vukićević J, Vuković J, Stojković J, Medenica L: [Dermatomyositis associated with metastatic rectal adenocarcinoma: case report]. Med Pregl; 2009 Sep-Oct;62(9-10):473-5
Genetic Alliance. consumer health - Dermatomyositis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Dermatomyositis associated with metastatic rectal adenocarcinoma: case report].
  • Association of dermatomyositis with malignant conditions has been described in various studies.
  • We present a patient with paraneoplastic dermatomyositis associated with metastatic rectal adenocarcinoma.
  • According to the medical documents and history, he underwent surgery because of rectal adenocarcinoma in April 2006.
  • The diagnosis of dermatomyositis was based on: characteristic clinical picture; the elevated serum level of following enzymes: creatinine kinase, lactate dehydrogenase; the presence of anti-Mi 2 antibodies in serum; electromyographic finding; and by histology of the muscle biopsy.
  • Paraneoplastic nature of dermatomyositis was confirmed by computer tomography of the abdomen which revealed multiple deposits in the liver, by explorative laparotomy showing peritoneal dissemination and histopathological analysis that verified metastatic adenocarcinoma of the rectum.
  • CONCLUSION: We report a case of paraneoplastic dermatomyositis associated with metastatic rectal adenocarcinoma and lethal outcome, and suggest a comprehensive evaluation of patients with dermatomyositis older than 50 years in order to exclude or verify the occult malignancy.
  • [MeSH-major] Adenocarcinoma / secondary. Dermatomyositis / complications. Paraneoplastic Syndromes / complications. Rectal Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20391745.001).
  • [ISSN] 0025-8105
  • [Journal-full-title] Medicinski pregled
  • [ISO-abbreviation] Med. Pregl.
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


81. Baatrup G, Breum B, Qvist N, Wille-Jørgensen P, Elbrønd H, Møller P, Hesselfeldt P: Transanal endoscopic microsurgery in 143 consecutive patients with rectal adenocarcinoma: results from a Danish multicenter study. Colorectal Dis; 2009 Mar;11(3):270-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transanal endoscopic microsurgery in 143 consecutive patients with rectal adenocarcinoma: results from a Danish multicenter study.
  • OBJECTIVE: The long-term results are presented on total survival, cancer-specific survival and recurrence in 143 consecutive patients treated with transanal endoscopic microsurgery (TEM) for adenocarcinoma of the rectum.
  • Five-year total survival was 66% and 5-year cancer-specific survival 87%.
  • Cancer-specific survival for T1 was 94%.
  • For cancer-specific survival T stage, radical resection, tumour size and recurrence were significant predictors.
  • [MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / surgery. Microsurgery / methods. Proctoscopy / methods. Rectal Neoplasms / mortality. Rectal Neoplasms / surgery
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Denmark. Female. Humans. Male. Middle Aged. Multivariate Analysis. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Postoperative Complications / mortality. Predictive Value of Tests. Probability. Prognosis. Registries. Reoperation / statistics & numerical data. Risk Assessment. Sex Factors. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18573118.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


82. Koh DM, George C, Temple L, Collins DJ, Toomey P, Raja A, Bett N, Farhat S, Husband JE, Brown G: Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol; 2010 Jun;194(6):W505-13
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
  • OBJECTIVE: The purpose of this study was to evaluate the diagnostic accuracy of the pattern of nodal enhancement at MRI enhanced with ultrasmall superparamagnetic iron oxide (USPIO) in the nodal classification of rectal cancer in pathologically matched mesorectal lymph nodes.
  • SUBJECTS AND METHODS: Twenty-five patients with adenocarcinoma of the rectum underwent prospective evaluation with 3-mm axial T2-weighted and USPIO-enhanced T2*-weighted MRI before surgery.
  • Mesorectal nodes visible at in vivo MRI were independently scored by two radiologists as malignant or nonmalignant according to morphologic criteria (irregular nodal contour, heterogeneous signal intensity) on T2-weighted MR images and according to USPIO enhancement pattern on T2*-weighted MR images.
  • RESULTS: After surgery, radiologic-pathologic comparison of 126 mesorectal nodes (116 benign, 10 malignant) was possible.
  • [MeSH-major] Adenocarcinoma / pathology. Dextrans. Ferrosoferric Oxide. Lymphatic Metastasis / pathology. Magnetic Resonance Imaging / methods. Rectal Neoplasms / pathology
  • [MeSH-minor] Aged. Contrast Media. Female. Humans. Image Interpretation, Computer-Assisted. Magnetite Nanoparticles. Male. Middle Aged. Neoplasm Staging. Predictive Value of Tests. Prognosis. Prospective Studies. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20489069.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Magnetite Nanoparticles; 0 / ferumoxtran-10; K3R6ZDH4DU / Dextrans; XM0M87F357 / Ferrosoferric Oxide
  •  go-up   go-down


83. Wolberink SV, Beets-Tan RG, de Haas-Kock DF, van de Jagt EJ, Span MM, Wiggers T: Multislice CT as a primary screening tool for the prediction of an involved mesorectal fascia and distant metastases in primary rectal cancer: a multicenter study. Dis Colon Rectum; 2009 May;52(5):928-34
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multislice CT as a primary screening tool for the prediction of an involved mesorectal fascia and distant metastases in primary rectal cancer: a multicenter study.
  • METHODS: A total of 250 patients with adenocarcinoma of the rectum underwent multislice CT scans of the chest and abdomen before undergoing total mesorectal excision.
  • The overall sensitivity for mid-/high rectal tumors was 76.1 percent and the overall specificity was 96.3 percent.
  • CONCLUSIONS: Multislice CT can be used for the assessment of mesorectal fascia involvement in primary rectal cancer, especially those located in the middle rectum and the high rectum; however, in the prediction of an involved margin of tumors located in the distal rectum, the accuracy of multislice CT falls short.
  • [MeSH-major] Adenocarcinoma / pathology. Fascia / pathology. Liver Neoplasms / diagnosis. Lymphatic Metastasis / diagnosis. Rectal Neoplasms / pathology. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19502858.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


84. MERCURY Study Group: Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology; 2007 Apr;243(1):132-9
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.
  • PURPOSE: To prospectively evaluate the accuracy of magnetic resonance (MR) imaging in depicting the extramural depth of tumor invasion in patients who have rectal cancer, with histopathologic results as the reference standard.
  • MATERIALS AND METHODS: The Magnetic Resonance Imaging and Rectal Cancer European Equivalence (MERCURY) Study received ethics approval from all participating centers, and all patients gave informed consent.
  • Consecutive patients (n = 679) with adenocarcinoma of the rectum consented to participate.
  • [MeSH-major] Adenocarcinoma / pathology. Magnetic Resonance Imaging / methods. Rectal Neoplasms / pathology

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Radiology. 2008 Feb;246(2):647; author reply 647-8 [18227560.001]
  • (PMID = 17329685.001).
  • [ISSN] 0033-8419
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


85. Damin DC, Tolfo GC, Rosito MA, Spiro BL, Kliemann LM: Sentinel lymph node in patients with rectal cancer invading the anal canal. Tech Coloproctol; 2010 Jun;14(2):133-9
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel lymph node in patients with rectal cancer invading the anal canal.
  • BACKGROUND: To assess the feasibility of the sentinel lymph node procedure in patients with rectal cancer extending to the anal canal.
  • METHODS: Between January 2005 and April 2008, 15 patients with adenocarcinoma of the rectum with direct invasion of the anal canal and no clinical evidence of inguinal involvement were prospectively enrolled in the study.
  • Four patients (26.7%) had sentinel nodes identified as positive for metastatic adenocarcinoma.
  • CONCLUSIONS: The standardized procedure was highly effective in sampling inguinal sentinel nodes in very low rectal cancers, allowing the detection of subclinical metastatic disease.
  • Although this technique can be potentially useful for a subgroup of patients with isolated inguinal metastases, it cannot be routinely recommended for patients with rectal tumors invading the anal canal at this moment.
  • [MeSH-major] Adenocarcinoma / secondary. Anal Canal. Inguinal Canal. Rectal Neoplasms / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prospective Studies

  • Genetic Alliance. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20424879.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


86. Corner C, Bryant L, Chapman C, Glynne-Jones R, Hoskin PJ: High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Brachytherapy; 2010 Jan-Mar;9(1):66-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
  • PURPOSE: High-dose-rate (HDR) intraluminal brachytherapy for advanced or inoperable tumors of the rectum has been used both palliatively and to dose escalate after chemoradiation for curative treatment.
  • METHODS: Between 1993 and 2007, 79 patients were treated with HDR afterloading brachytherapy for rectal cancer; 70 patients had adenocarcinoma of the rectum; and 9 patients had squamous cell carcinoma of the anal canal.
  • The most common symptom was rectal bleeding, which was controlled with a complete response rate of 63%.
  • Six patients reported late toxicity with three cases of rectal ulcer, two strictures, and one fistula.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Brachytherapy / methods. Carcinoma, Squamous Cell / radiotherapy. Rectal Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
  • (PMID = 19846349.001).
  • [ISSN] 1873-1449
  • [Journal-full-title] Brachytherapy
  • [ISO-abbreviation] Brachytherapy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R: Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol; 2007 Feb;188(2):442-51
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.
  • OBJECTIVE: The purpose of this study was to use MRI to compare the morphologic features of rectal cancer before and 6 weeks after chemotherapy and radiation treatment to correlate the posttreatment MRI appearances with the histologic findings in resected tumors.
  • MATERIALS AND METHODS: High-resolution T2-weighted MRI was performed before and immediately after a standardized 5-week course of chemoradiation therapy in the care of 30 patients with locally advanced adenocarcinoma of the rectum.
  • Errors were caused by the presence of considerable tumor, rectal wall fibrosis, and mucinous tumors.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Magnetic Resonance Imaging / methods. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / prevention & control. Rectal Neoplasms / diagnosis. Rectal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17242254.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Velenik V, Anderluh F, Oblak I, Strojan P, Zakotnik B: Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. Croat Med J; 2006 Oct;47(5):693-700
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.
  • AIM: To evaluate the efficacy and toxicity of preoperative chemoradiotherapy with capecitabine in locally advanced rectal cancer.
  • METHODS: Between June 2004 and January 2005, 57 patients with operable, clinical stage II-III adenocarcinoma of the rectum entered the prospective phase II study.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Radiation-Sensitizing Agents / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. CAPECITABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Chemother Pharmacol. 2000;45(4):291-7 [10755317.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):346-53 [15913913.001]
  • [Cites] Bioorg Med Chem. 2000 Jul;8(7):1697-706 [10976516.001]
  • [Cites] Eur J Cancer. 2001 Mar;37(5):597-604 [11290435.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):675-9 [12062611.001]
  • [Cites] Lancet Oncol. 2002 Jul;3(7):415-24 [12142171.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):403-8 [12243814.001]
  • [Cites] Clin Ther. 2004 Apr;26(4):579-89 [15189755.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):110-5 [8996131.001]
  • [Cites] N Engl J Med. 1997 Apr 3;336(14):980-7 [9091798.001]
  • [Cites] Dis Colon Rectum. 1997 Feb;40(2):131-9 [9075745.001]
  • [Cites] Semin Oncol. 1997 Oct;24(5 Suppl 18):S18-8-S18-18 [9420016.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):301-8 [9440757.001]
  • [Cites] Dis Colon Rectum. 1998 May;41(5):543-9; discussion 549-51 [9593234.001]
  • [Cites] Biochem Pharmacol. 1998 Apr 1;55(7):1091-7 [9605432.001]
  • [Cites] Eur J Cancer. 1998 Jul;34(8):1274-81 [9849491.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):13-47 [10758303.001]
  • (PMID = 17042060.001).
  • [ISSN] 1332-8166
  • [Journal-full-title] Croatian medical journal
  • [ISO-abbreviation] Croat. Med. J.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Radiation-Sensitizing Agents; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  • [Other-IDs] NLM/ PMC2080466
  •  go-up   go-down


89. Tsalis K, Ganidou M, Blouhos K, Vasiliadis K, Betsis D: Transfusion-related acute lung injury: a life-threatening transfusion reaction. Med Sci Monit; 2005 May;11(5):CS19-22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE REPORT: A 56-year-old woman had undergone a low anterior resection in 2002 because of a Duke's stage D adenocarcinoma of the rectum.
  • The diagnosis of TRALI syndrome was based on clinical signs and symptoms.
  • Early diagnosis and treatment improves survival and usually results in full recovery.
  • TRALI remains a clinical diagnosis in an appropriate setting, supported by serologic studies if these are available.
  • [MeSH-minor] Acute Disease. Adenocarcinoma / surgery. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / surgery. Pulmonary Edema / etiology. Pulmonary Edema / therapy. Rectal Neoplasms / surgery. Respiratory Distress Syndrome, Adult / etiology. Respiratory Distress Syndrome, Adult / therapy. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15874891.001).
  • [ISSN] 1234-1010
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  •  go-up   go-down


90. Vermaas M, Gosselink MP, Ferenschild FT, van den Aardweg E, Lont HE, Kemperman HW, van der Harst E, Tetteroo GW, Oostenbroek RJ, Dijkhuis CM, Eggermont AM, de Wilt JH: Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Eur J Surg Oncol; 2007 Sep;33(7):862-7
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
  • INTRODUCTION: After publication of the results of the Dutch TME-trial preoperative radiotherapy followed by TME-surgery was introduced in July 2001 in the region of the comprehensive cancer centre Rotterdam as standard treatment for rectal cancer.
  • The aim of this study is to identify the compliance to a new standardized treatment protocol i.e. the introduction of preoperative radiotherapy and to analyze the results of rectal cancer treatment in the Cancer Centre Rotterdam Region.
  • PATIENTS AND METHODS: A total of 521 patients with adenocarcinoma of the rectum were included in the period from 2001 to 2003.
  • RESULTS: There was a significant increase of preoperative radiotherapy for patients with a tumour in the lower two-third of the rectum (21% versus 69%, p<0.001).
  • CONCLUSION: The regional quality of rectal cancer surgery is conform preset quality-demands.
  • Pathology reports improved during registration, which illustrates the importance of registration to assess and improve quality of rectal cancer treatment.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Preoperative Care / methods. Rectal Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17257804.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


91. Ngan SY, Fisher R, Burmeister BH, Mackay J, Goldstein D, Kneebone A, Schache D, Joseph D, McKendrick J, Leong T, McClure B, Rischin D: Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum; 2005 Jul;48(7):1389-96
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801).
  • PURPOSE: This article reports the overall survival, failure-free survival, local failure, and late radiation toxicity of a phase II trial of preoperative radiotherapy with continuous infusion 5-fluorouracil for rectal cancer after a minimum 3.5 years of follow-up.
  • METHODS: Eligible patients were those with newly diagnosed localized adenocarcinoma of the rectum, within 12 cm of the anal verge, staged T3-T4 and deemed suitable for curative resection.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Fluorouracil / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Dose Fractionation. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15906126.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] U3P01618RT / Fluorouracil
  •  go-up   go-down


92. Laurent A, Parc Y, McNamara D, Parc R, Tiret E: Colonic J-pouch-anal anastomosis for rectal cancer: a prospective, randomized study comparing handsewn vs. stapled anastomosis. Dis Colon Rectum; 2005 Apr;48(4):729-34
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic J-pouch-anal anastomosis for rectal cancer: a prospective, randomized study comparing handsewn vs. stapled anastomosis.
  • PURPOSE: Colonic J-pouch-anal anastomosis performed after complete proctectomy and total mesorectal excision for adenocarcinoma of the rectum can be handsewn or stapled.
  • METHODS: Between January 1999 and May 2001, all patients with rectal adenocarcinoma requiring total mesorectal excision were randomized intraoperatively to handsewn or stapled anastomosis.
  • [MeSH-major] Adenocarcinoma / surgery. Colonic Pouches. Postoperative Complications. Proctocolectomy, Restorative / methods. Rectal Neoplasms / surgery. Suture Techniques. Sutures

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15719189.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


93. Ballonoff A, Kavanagh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter TE: Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol; 2008 Jun;31(3):264-70
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
  • OBJECTIVES: A prospective phase II trial was conducted to evaluate the feasibility, safety, and pathologic response rate of preoperative capecitabine and accelerated synchronous integrated boost (SIB) intensity-modulated radiotherapy (IMRT) in patients with locally advanced rectal cancer.
  • METHODS: Consenting operable patients with stage II or III adenocarcinoma of the rectum received capecitabine (825 mg/m2 PO BID, 5 days/wk x 5 weeks) and SIB-IMRT delivering 55 Gy (2.2 Gy/fraction) to the gross tumor while simultaneously delivering 45 Gy (1.8 Gy/fraction) to the regional lymph nodes and areas at risk for harboring microscopic disease.
  • CONCLUSIONS: Preoperative chemoradiation with capecitabine and SIB-IMRT is well tolerated and results in an encouraging pCR rate for patients with locally advanced rectal cancer.
  • [MeSH-major] Adenocarcinoma / therapy. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Radiotherapy, Intensity-Modulated. Rectal Neoplasms / therapy
  • [MeSH-minor] Aged. Antimetabolites, Antineoplastic / administration & dosage. Capecitabine. Chemotherapy, Adjuvant. Diarrhea / chemically induced. Disease-Free Survival. Feasibility Studies. Humans. Male. Middle Aged. Neoplasm Staging. Premedication. Prospective Studies. Radiotherapy Dosage. Radiotherapy, Adjuvant. Remission Induction

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18525306.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


94. Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, Ojerskog B, Damber L, Johansson R: The Swedish rectal cancer registry. Br J Surg; 2007 Oct;94(10):1285-92
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Swedish rectal cancer registry.
  • BACKGROUND: An audit of all patients with rectal cancer in Sweden was launched in 1995.
  • This is the first report from the Swedish Rectal Cancer Registry (SRCR).
  • METHODS: Between 1995 and 2003, 13 434 patients treated for adenocarcinoma of the rectum were registered with the SRCR; there were approximately 1500 new patients annually.
  • The 5-year cancer-specific survival rate was 62.3 per cent.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / mortality. Postoperative Complications / mortality. Registries. Survival Analysis. Sweden / epidemiology. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2007 British Journal of Surgery Society Ltd.
  • (PMID = 17661309.001).
  • [ISSN] 1365-2168
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


95. Freedman GM, Meropol NJ, Sigurdson ER, Hoffman J, Callahan E, Price R, Cheng J, Cohen S, Lewis N, Watkins-Bruner D, Rogatko A, Konski A: Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys; 2007 Apr 1;67(5):1389-93
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
  • PURPOSE: To determine the safety and efficacy of preoperative hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) and an incorporated boost with concurrent capecitabine in patients with locally advanced rectal cancer.
  • METHODS AND MATERIALS: The eligibility criteria included adenocarcinoma of the rectum, T3-T4 and/or N1-N2 disease, performance status 0 or 1, and age > or =18 years.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Radiotherapy, Intensity-Modulated / adverse effects. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17394942.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


96. Ferenschild FT, Dawson I, de Wilt JH, de Graaf EJ, Groenendijk RP, Tetteroo GW: Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis; 2009 Aug;24(8):923-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.
  • OBJECTIVE: The aim of this study was to review the results and long-term outcome after total mesorectal excision (TME) for adenocarcinoma of the rectum in an unselected population in a community teaching hospital.
  • MATERIALS AND METHODS: Between 1996 and 2003, 210 patients with rectal cancer were identified in our prospective database, containing patient characteristics, radiotherapy plans, operation notes, histopathological reports, and follow-up details.
  • RESULTS: The mean age at diagnosis was 69 years (range 40-91 years).
  • A total of 145 patients were treated by anterior rectal resection; 65 patients had to undergo an abdominoperineal resection (APR).
  • CONCLUSIONS: Patients with rectal cancer can safely be treated with TME in a community teaching hospital and leads to a good overall survival and an excellent local control.
  • In patients aged above 80, treatment-related mortality is an important competitive risk factor, which obscures the positive effect of modern rectal cancer treatment.
  • [MeSH-major] Adenocarcinoma / surgery. Digestive System Surgical Procedures. Outcome and Process Assessment (Health Care). Quality of Health Care. Rectal Neoplasms / surgery. Workload
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Databases as Topic. Disease-Free Survival. Feasibility Studies. Hospitals, Community / statistics & numerical data. Hospitals, Teaching / statistics & numerical data. Humans. Kaplan-Meier Estimate. Middle Aged. Neoplasm Recurrence, Local. Proportional Hazards Models. Risk Assessment. Risk Factors. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2000 Jul 8;356(9224):93-6 [10963244.001]
  • [Cites] Arch Surg. 1998 Jun;133(6):608-11; discussion 611-2 [9637458.001]
  • [Cites] Int J Surg Investig. 1999;1(3):253-5 [11341619.001]
  • [Cites] N Engl J Med. 2001 Aug 30;345(9):638-46 [11547717.001]
  • [Cites] J Clin Oncol. 2002 Apr 1;20(7):1729-34 [11919228.001]
  • [Cites] Eur J Cancer. 2002 May;38(7):919-36 [11978517.001]
  • [Cites] Int J Cancer. 2002 Oct 20;101(6):545-8 [12237895.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1311-20 [12654443.001]
  • [Cites] Dis Colon Rectum. 2004 Jan;47(1):48-58 [14719151.001]
  • [Cites] J Clin Oncol. 2004 May 15;22(10):1785-96 [15067027.001]
  • [Cites] Eur J Surg Oncol. 1998 Dec;24(6):528-35 [9870729.001]
  • [Cites] Eur J Surg Oncol. 1999 Aug;25(4):368-74 [10419706.001]
  • [Cites] Colorectal Dis. 2004 Nov;6(6):462-9 [15521937.001]
  • [Cites] Radiology. 2005 Jan;234(1):179-88 [15550372.001]
  • [Cites] Tumour Biol. 2004 Sep-Dec;25(5-6):228-34 [15627885.001]
  • [Cites] Br J Surg. 2005 May;92(5):615-23 [15779071.001]
  • [Cites] Colorectal Dis. 2005 Jul;7(4):403-5 [15932567.001]
  • [Cites] Dis Colon Rectum. 2005 May;48(5):918-28 [15785886.001]
  • [Cites] Eur J Surg Oncol. 2005 Aug;31(6):681-8 [16023947.001]
  • [Cites] J Clin Oncol. 2005 Sep 1;23(25):6199-206 [16135487.001]
  • [Cites] Semin Ultrasound CT MR. 2005 Aug;26(4):259-68 [16152740.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1309-15 [16125874.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9257-64 [16361623.001]
  • [Cites] Colorectal Dis. 2006 Mar;8(3):177-85 [16466556.001]
  • [Cites] World J Surg. 2006 Apr;30(4):598-604 [16568224.001]
  • [Cites] Colorectal Dis. 2006 Jul;8(6):471-9 [16784465.001]
  • [Cites] Dis Colon Rectum. 2006 Sep;49(9):1257-65 [16912909.001]
  • [Cites] Eur J Surg Oncol. 2007 Mar;33(2):183-7 [17174516.001]
  • [Cites] Ann Surg. 2007 Nov;246(5):693-701 [17968156.001]
  • [Cites] Colorectal Dis. 2008 Jan;10(1):48-57 [18028472.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):382-9 [17669613.001]
  • [Cites] Lancet Oncol. 2008 May;9(5):494-501 [18452860.001]
  • [Cites] World J Surg. 2008 Jun;32(6):1124-9 [18259805.001]
  • [Cites] World J Surg. 2008 Jun;32(6):1116-23 [18330627.001]
  • [Cites] Colorectal Dis. 2008 Sep;10(7):715-21 [18318752.001]
  • [Cites] J Clin Oncol. 2006 Sep 1;24(25):4078-84 [16943525.001]
  • [Cites] J Surg Oncol. 2004 Jun 1;86(3):115-21 [15170648.001]
  • [Cites] Ann Surg. 2004 Aug;240(2):260-8 [15273550.001]
  • [Cites] Front Radiat Ther Oncol. 2004;38:1-12 [15458181.001]
  • [Cites] Br J Surg. 1982 Oct;69(10):613-6 [6751457.001]
  • [Cites] Lancet. 1986 Jun 28;1(8496):1479-82 [2425199.001]
  • [Cites] Lancet. 1986 Nov 1;2(8514):996-9 [2430152.001]
  • [Cites] Int J Colorectal Dis. 1988 Jun;3(2):127-31 [3045231.001]
  • [Cites] Lancet. 1993 Feb 20;341(8843):457-60 [8094488.001]
  • [Cites] N Engl J Med. 1997 Apr 3;336(14):980-7 [9091798.001]
  • [Cites] Dis Colon Rectum. 1997 Jul;40(7):747-51 [9221846.001]
  • [Cites] J Am Coll Surg. 1997 Aug;185(2):105-13 [9249076.001]
  • [Cites] Anticancer Res. 2000 Nov-Dec;20(6D):5195-8 [11326694.001]
  • (PMID = 19488771.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC2699389
  •  go-up   go-down


97. Hirata K, Kanemitsu S, Nakayama Y, Nagata N, Itoh H, Ohnishi H, Ishikawa H, Furukawa Y, HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum (JSCCR): A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Am J Gastroenterol; 2006 Jan;101(1):193-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
  • BACKGROUND: One of the clinical features of hereditary nonpolyposis colorectal cancer (HNPCC) is a high incidence of multiple primary neoplasms arising in various organs including the gastrointestinal and genitourinary tracts.
  • METHODS AND RESULTS: A 40-yr-old Japanese patient, who had a past history of adenocarcinoma of the rectum and transitional cell carcinoma of the urinary bladder, developed a liposarcoma in his left thigh.
  • The expression of MSH2 in the liposarcoma and rectal cancer of the patient was analyzed by immunohistochemistry, which revealed loss of MSH2 expression in the tumors.
  • Since an immunohistochemical analysis showed no nuclear staining for MSH2 protein in the liposarcoma as well as the rectal cancer, the loss of wild-type MSH2 protein was thus considered to possibly play a role in the development of liposarcoma in HNPCC patients.
  • [MeSH-minor] Adult. Base Pair Mismatch. Carcinoma, Transitional Cell / diagnosis. Carcinoma, Transitional Cell / pathology. Follow-Up Studies. Germ-Line Mutation. Humans. Male. Risk Assessment


98. Ugidos L, Delgado S, Conill C, Ginés A, Gallego R, Ayuso JR, Miquel R, Tosca M, de Lacy A, Castells A, Maurel J: Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients. Invest New Drugs; 2009 Jun;27(3):262-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.
  • BACKGROUND: To analyze the feasibility of capecitabine with weekly irinotecan and concurrent radiotherapy followed by laparoscopic-total mesorectal excision (LTME) in rectal cancer patients.
  • METHODS: Eligible criteria included adenocarcinoma of the rectum staged by endoscopic ultrasonography (u), spiral abdominal and pelvic CT and chest X-ray.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Camptothecin / analogs & derivatives. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Laparoscopy. Neoadjuvant Therapy. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18923810.001).
  • [ISSN] 1573-0646
  • [Journal-full-title] Investigational new drugs
  • [ISO-abbreviation] Invest New Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; 7673326042 / irinotecan; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


99. Agboola AO, Adekanmbi FA, Musa AA, Sotimehin AS, Deji-Agboola AM, Shonubi AM, Oyebadejo TY, Banjo AA: Pattern of childhood malignant tumours in a teaching hospital in south-western Nigeria. Med J Aust; 2009 Jan 5;190(1):12-4
MedlinePlus Health Information. consumer health - Cancer in Children.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pattern of childhood malignant tumours in a teaching hospital in south-western Nigeria.
  • OBJECTIVE: To document general baseline data on the patterns of childhood malignant tumours at a teaching hospital in south-western Nigeria.
  • RESULTS: 77 children were diagnosed with malignant tumours (an average of seven diagnoses per year); 46 were boys (60%), giving a male-to-female ratio of 1.5 : 1.
  • One case each of medullary thyroid carcinoma, adenocarcinoma of the rectum, invasive mucinous carcinoma of the colon were also identified.
  • CONCLUSION: These data suggest that Burkitt's lymphoma is the most common childhood malignant tumour in our geographic area of south-western Nigeria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19120001.001).
  • [ISSN] 0025-729X
  • [Journal-full-title] The Medical journal of Australia
  • [ISO-abbreviation] Med. J. Aust.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


100. Bachet JB, Rougier P, de Gramont A, André T: [Rectal cancer and adjuvant chemotherapy: which conclusions?]. Bull Cancer; 2010 Jan;97(1):107-22
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rectal cancer and adjuvant chemotherapy: which conclusions?].
  • [Transliterated title] Cancer du rectum et chimiothérapie adjuvante: quelles conclusions?
  • Adenocarcinoma of the rectum represents about a third of cases of colorectal cancer, with an annual incidence of 12,000 cases in France.
  • On the contrary of colon cancer, the benefice of adjuvant chemotherapy in rectal cancer has not been definitively proved, more because this question was assessed in few recent studies than because negative results.
  • Preoperative radiochemotherapy is now the reference treatment for mid and lower rectal cancers, and allow to increase the local control without improvement of progression free survival and overall survival.
  • The data of the "historical studies" of adjuvant treatment in rectal cancer published before 1990, of the meta-analysis of adjuvant trials in rectal cancer and of the QUASAR study suggest that adjuvant chemotherapy with fluoropyrimidines (intravenous or oral), in absence of pre-operative treatment, decrease the risk of metastatic relapse after curative surgery for a rectal cancer of stage II or III.
  • This benefice seems similar to the one observed in colon cancer.
  • The French recommendations are to discuss the indication of adjuvant chemotherapy by fluoropyrimidines in cases of stage III rectal cancer on histopathologic reports and no chemotherapy in case of stade II.
  • Despite the fact that none study have assessed a combination of fluoropyrimidines and oxaliplatin in adjuvant setting in rectal cancer, like in colon cancer, the Folfox4, modified Folfox6 or Xelox regimens are valid options in stage III (experts opinion).
  • [MeSH-major] Adenocarcinoma / drug therapy. Rectal Neoplasms / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19965305.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 58
  •  go-up   go-down






Advertisement